{ "source": "Nasdaq Nordic Company News", "fetcher_build": "2026-08-03-nasdaq-cns-annual-period-v5.0.10", "status": "retrieved", "company": "AstraZeneca PLC", "reports": [ { "source": "Nasdaq Nordic", "fetcher_build": "2026-08-03-nasdaq-cns-annual-period-v5.0.10", "retrieved_at": "2026-08-03T17:13:30Z", "company": "AstraZeneca PLC", "title": "Half-year Financial Report", "category": "Half Year financial report", "date": "2026-07-27", "language": "en", "report_type": "interim-report", "fiscal_year": 2026, "quarter": "q2", "period": "2026-q2", "report_key": "2026:q2", "release_url": "https://view.news.eu.nasdaq.com/view?id=b9eba205211cc6b46064a369424acb25b&lang=en&src=listed", "release_html_path": "D:\\Web\\aktieanalys\\data\\astrazeneca-plc\\nasdaq-reports\\reports\\2026-q2\\release.html", "release_text_path": "D:\\Web\\aktieanalys\\data\\astrazeneca-plc\\nasdaq-reports\\reports\\2026-q2\\release.txt", "attachments": [ { "label": "FINAL - 26 JUL AZN 2026 Q2 - Announcement.pdf", "url": "https://attachment.news.eu.nasdaq.com/a549985d90a9c3e03c64f2628a9fd36bb", "final_url": "https://attachment.news.eu.nasdaq.com/a549985d90a9c3e03c64f2628a9fd36bb", "filename": "FINAL_-_26_JUL_AZN_2026_Q2_-_Announcement.pdf", "local_path": "D:\\Web\\aktieanalys\\data\\astrazeneca-plc\\nasdaq-reports\\reports\\2026-q2\\FINAL_-_26_JUL_AZN_2026_Q2_-_Announcement.pdf", "content_type": "application/pdf", "size": 1659271, "sha256": "49da44dc4c459daeb44d39186f1d0ea3a197ccd18b202f691782fa4a0c83753b", "extraction": { "source_path": "D:\\Web\\aktieanalys\\data\\astrazeneca-plc\\nasdaq-reports\\reports\\2026-q2\\FINAL_-_26_JUL_AZN_2026_Q2_-_Announcement.pdf", "filename": "FINAL_-_26_JUL_AZN_2026_Q2_-_Announcement.pdf", "extension": ".pdf", "size": 1659271, "sha256": "49da44dc4c459daeb44d39186f1d0ea3a197ccd18b202f691782fa4a0c83753b", "status": "extracted", "text_path": "D:\\Web\\aktieanalys\\data\\astrazeneca-plc\\nasdaq-reports\\reports\\2026-q2\\extracted\\FINAL_-_26_JUL_AZN_2026_Q2_-_Announcement\\FINAL_-_26_JUL_AZN_2026_Q2_-_Announcement.txt", "text_chars": 148994, "metadata": { "page_count": 43, "empty_pages": 0, "encrypted": false }, "children": [], "warnings": [], "manifest_path": "D:\\Web\\aktieanalys\\data\\astrazeneca-plc\\nasdaq-reports\\reports\\2026-q2\\extracted\\FINAL_-_26_JUL_AZN_2026_Q2_-_Announcement\\FINAL_-_26_JUL_AZN_2026_Q2_-_Announcement.extraction.json" } }, { "label": "07271901.pdf", "url": "https://attachment.news.eu.nasdaq.com/a61ea78693df5e524a6c64d49792c576e", "final_url": "https://attachment.news.eu.nasdaq.com/a61ea78693df5e524a6c64d49792c576e", "filename": "07271901.pdf", "local_path": "D:\\Web\\aktieanalys\\data\\astrazeneca-plc\\nasdaq-reports\\reports\\2026-q2\\07271901.pdf", "content_type": "application/pdf", "size": 341727, "sha256": "0730ee70036f5ff193a424f724004e4be5bac0bbcecf2356f319d07085980d1d", "extraction": { "source_path": "D:\\Web\\aktieanalys\\data\\astrazeneca-plc\\nasdaq-reports\\reports\\2026-q2\\07271901.pdf", "filename": "07271901.pdf", "extension": ".pdf", "size": 341727, "sha256": "0730ee70036f5ff193a424f724004e4be5bac0bbcecf2356f319d07085980d1d", "status": "extracted", "text_path": "D:\\Web\\aktieanalys\\data\\astrazeneca-plc\\nasdaq-reports\\reports\\2026-q2\\extracted\\07271901\\07271901.txt", "text_chars": 2380, "metadata": { "page_count": 1, "empty_pages": 0, "encrypted": false }, "children": [], "warnings": [], "manifest_path": "D:\\Web\\aktieanalys\\data\\astrazeneca-plc\\nasdaq-reports\\reports\\2026-q2\\extracted\\07271901\\07271901.extraction.json" } }, { "label": "http://www.rns-pdf.londonstockexchange.com/rns/9440N_1-2026-7-26.pdf", "url": "http://www.rns-pdf.londonstockexchange.com/rns/9440N_1-2026-7-26.pdf", "final_url": "https://www.rns-pdf.londonstockexchange.com/rns/9440N_1-2026-7-26.pdf", "filename": "http_www.rns-pdf.londonstockexchange.com_rns_9440N_1-2026-7-26.pdf", "local_path": "D:\\Web\\aktieanalys\\data\\astrazeneca-plc\\nasdaq-reports\\reports\\2026-q2\\http_www.rns-pdf.londonstockexchange.com_rns_9440N_1-2026-7-26.pdf", "content_type": "application/pdf", "size": 1659271, "sha256": "49da44dc4c459daeb44d39186f1d0ea3a197ccd18b202f691782fa4a0c83753b", "extraction": { "source_path": "D:\\Web\\aktieanalys\\data\\astrazeneca-plc\\nasdaq-reports\\reports\\2026-q2\\http_www.rns-pdf.londonstockexchange.com_rns_9440N_1-2026-7-26.pdf", "filename": "http_www.rns-pdf.londonstockexchange.com_rns_9440N_1-2026-7-26.pdf", "extension": ".pdf", "size": 1659271, "sha256": "49da44dc4c459daeb44d39186f1d0ea3a197ccd18b202f691782fa4a0c83753b", "status": "extracted", "text_path": "D:\\Web\\aktieanalys\\data\\astrazeneca-plc\\nasdaq-reports\\reports\\2026-q2\\extracted\\http_www.rns-pdf.lo.com_rns_9440N_1-2026\\http_www.rns-pdf.londons.com_rns_9440N_1-2026.txt", "text_chars": 148994, "metadata": { "page_count": 43, "empty_pages": 0, "encrypted": false }, "children": [], "warnings": [], "manifest_path": "D:\\Web\\aktieanalys\\data\\astrazeneca-plc\\nasdaq-reports\\reports\\2026-q2\\extracted\\http_www.rns-pdf.lo.com_rns_9440N_1-2026\\http_www.rns-pdf.londons.com_rns_9440N_1-2026.extraction.json" } } ], "announcement_id": "1455612", "status": "retrieved" }, { "source": "Nasdaq Nordic", "fetcher_build": "2026-08-03-nasdaq-cns-annual-period-v5.0.10", "retrieved_at": "2026-08-03T17:13:46Z", "company": "AstraZeneca PLC", "title": "1st Quarter Results", "category": "Interim report (Q1 and Q3)", "date": "2026-04-29", "language": "en", "report_type": "interim-report", "fiscal_year": 2026, "quarter": "q1", "period": "2026-q1", "report_key": "2026:q1", "release_url": "https://view.news.eu.nasdaq.com/view?id=bdd9ce7a1528b2e8b67e99a7adf0249cd&lang=en&src=listed", "release_html_path": "D:\\Web\\aktieanalys\\data\\astrazeneca-plc\\nasdaq-reports\\reports\\2026-q1\\release.html", "release_text_path": "D:\\Web\\aktieanalys\\data\\astrazeneca-plc\\nasdaq-reports\\reports\\2026-q1\\release.txt", "attachments": [ { "label": "POST DC - 28 APR AZN 2026 Q1 - Announcement.pdf", "url": "https://attachment.news.eu.nasdaq.com/a2a52657347f9a897ecca69cecd31b015", "final_url": "https://attachment.news.eu.nasdaq.com/a2a52657347f9a897ecca69cecd31b015", "filename": "POST_DC_-_28_APR_AZN_2026_Q1_-_Announcement.pdf", "local_path": "D:\\Web\\aktieanalys\\data\\astrazeneca-plc\\nasdaq-reports\\reports\\2026-q1\\POST_DC_-_28_APR_AZN_2026_Q1_-_Announcement.pdf", "content_type": "application/pdf", "size": 1413188, "sha256": "9cd13c17549a1e83e860c6b713be2fd22f2d7e870c10ff485d067e2bb81b8d65", "extraction": { "source_path": "D:\\Web\\aktieanalys\\data\\astrazeneca-plc\\nasdaq-reports\\reports\\2026-q1\\POST_DC_-_28_APR_AZN_2026_Q1_-_Announcement.pdf", "filename": "POST_DC_-_28_APR_AZN_2026_Q1_-_Announcement.pdf", "extension": ".pdf", "size": 1413188, "sha256": "9cd13c17549a1e83e860c6b713be2fd22f2d7e870c10ff485d067e2bb81b8d65", "status": "extracted", "text_path": "D:\\Web\\aktieanalys\\data\\astrazeneca-plc\\nasdaq-reports\\reports\\2026-q1\\extracted\\POST_DC_-_28_APR_AZN_2026_Q1_-_Announcement\\POST_DC_-_28_APR_AZN_2026_Q1_-_Announcement.txt", "text_chars": 114348, "metadata": { "page_count": 37, "empty_pages": 0, "encrypted": false }, "children": [], "warnings": [], "manifest_path": "D:\\Web\\aktieanalys\\data\\astrazeneca-plc\\nasdaq-reports\\reports\\2026-q1\\extracted\\POST_DC_-_28_APR_AZN_2026_Q1_-_Announcement\\POST_DC_-_28_APR_AZN_2026_Q1_-_Announcement.extraction.json" } }, { "label": "2998C.pdf", "url": "https://attachment.news.eu.nasdaq.com/ac8ec8d3641fce7527851a84183a0f9e1", "final_url": "https://attachment.news.eu.nasdaq.com/ac8ec8d3641fce7527851a84183a0f9e1", "filename": "2998C.pdf", "local_path": "D:\\Web\\aktieanalys\\data\\astrazeneca-plc\\nasdaq-reports\\reports\\2026-q1\\2998C.pdf", "content_type": "application/pdf", "size": 389705, "sha256": "b06a4a42409d87a2a8d64a44974c0a34709b7aea8fec5a70a1881e9c369491e7", "extraction": { "source_path": "D:\\Web\\aktieanalys\\data\\astrazeneca-plc\\nasdaq-reports\\reports\\2026-q1\\2998C.pdf", "filename": "2998C.pdf", "extension": ".pdf", "size": 389705, "sha256": "b06a4a42409d87a2a8d64a44974c0a34709b7aea8fec5a70a1881e9c369491e7", "status": "extracted", "text_path": "D:\\Web\\aktieanalys\\data\\astrazeneca-plc\\nasdaq-reports\\reports\\2026-q1\\extracted\\2998C\\2998C.txt", "text_chars": 3028, "metadata": { "page_count": 2, "empty_pages": 0, "encrypted": false }, "children": [], "warnings": [], "manifest_path": "D:\\Web\\aktieanalys\\data\\astrazeneca-plc\\nasdaq-reports\\reports\\2026-q1\\extracted\\2998C\\2998C.extraction.json" } }, { "label": "http://www.rns-pdf.londonstockexchange.com/rns/2991C_1-2026-4-28.pdf", "url": "http://www.rns-pdf.londonstockexchange.com/rns/2991C_1-2026-4-28.pdf", "final_url": "https://www.rns-pdf.londonstockexchange.com/rns/2991C_1-2026-4-28.pdf", "filename": "http_www.rns-pdf.londonstockexchange.com_rns_2991C_1-2026-4-28.pdf", "local_path": "D:\\Web\\aktieanalys\\data\\astrazeneca-plc\\nasdaq-reports\\reports\\2026-q1\\http_www.rns-pdf.londonstockexchange.com_rns_2991C_1-2026-4-28.pdf", "content_type": "application/pdf", "size": 1413188, "sha256": "9cd13c17549a1e83e860c6b713be2fd22f2d7e870c10ff485d067e2bb81b8d65", "extraction": { "source_path": "D:\\Web\\aktieanalys\\data\\astrazeneca-plc\\nasdaq-reports\\reports\\2026-q1\\http_www.rns-pdf.londonstockexchange.com_rns_2991C_1-2026-4-28.pdf", "filename": "http_www.rns-pdf.londonstockexchange.com_rns_2991C_1-2026-4-28.pdf", "extension": ".pdf", "size": 1413188, "sha256": "9cd13c17549a1e83e860c6b713be2fd22f2d7e870c10ff485d067e2bb81b8d65", "status": "extracted", "text_path": "D:\\Web\\aktieanalys\\data\\astrazeneca-plc\\nasdaq-reports\\reports\\2026-q1\\extracted\\http_www.rns-pdf.lo.com_rns_2991C_1-2026\\http_www.rns-pdf.londons.com_rns_2991C_1-2026.txt", "text_chars": 114348, "metadata": { "page_count": 37, "empty_pages": 0, "encrypted": false }, "children": [], "warnings": [], "manifest_path": "D:\\Web\\aktieanalys\\data\\astrazeneca-plc\\nasdaq-reports\\reports\\2026-q1\\extracted\\http_www.rns-pdf.lo.com_rns_2991C_1-2026\\http_www.rns-pdf.londons.com_rns_2991C_1-2026.extraction.json" } } ], "announcement_id": "1438039", "status": "retrieved" }, { "source": "Nasdaq Nordic", "fetcher_build": "2026-08-03-nasdaq-cns-annual-period-v5.0.10", "retrieved_at": "2026-08-03T17:13:46Z", "company": "AstraZeneca PLC", "title": "Annual Financial Report", "category": "Annual Financial Report", "date": "2026-02-24", "language": "en", "report_type": "annual-report", "fiscal_year": 2025, "quarter": "annual", "period": "2025-annual", "report_key": "2025:annual", "release_url": "https://view.news.eu.nasdaq.com/view?id=bee501d54e0f7ff39fa376ba741a1c22a&lang=en&src=listed", "release_html_path": "D:\\Web\\aktieanalys\\data\\astrazeneca-plc\\nasdaq-reports\\reports\\2025-annual\\release.html", "release_text_path": "D:\\Web\\aktieanalys\\data\\astrazeneca-plc\\nasdaq-reports\\reports\\2025-annual\\release.txt", "attachments": [ { "label": "02245634.pdf", "url": "https://attachment.news.eu.nasdaq.com/a7bfe2ec257ad4f4cb110977f3d64c512", "final_url": "https://attachment.news.eu.nasdaq.com/a7bfe2ec257ad4f4cb110977f3d64c512", "filename": "02245634.pdf", "local_path": "D:\\Web\\aktieanalys\\data\\astrazeneca-plc\\nasdaq-reports\\reports\\2025-annual\\02245634.pdf", "content_type": "application/pdf", "size": 168972, "sha256": "a381ef16b21d3c2400de8cb47412c2d68353513c8e441c7e6b581d16a26f97a5", "extraction": { "source_path": "D:\\Web\\aktieanalys\\data\\astrazeneca-plc\\nasdaq-reports\\reports\\2025-annual\\02245634.pdf", "filename": "02245634.pdf", "extension": ".pdf", "size": 168972, "sha256": "a381ef16b21d3c2400de8cb47412c2d68353513c8e441c7e6b581d16a26f97a5", "status": "extracted", "text_path": "D:\\Web\\aktieanalys\\data\\astrazeneca-plc\\nasdaq-reports\\reports\\2025-annual\\extracted\\02245634\\02245634.txt", "text_chars": 2357, "metadata": { "page_count": 1, "empty_pages": 0, "encrypted": false }, "children": [], "warnings": [], "manifest_path": "D:\\Web\\aktieanalys\\data\\astrazeneca-plc\\nasdaq-reports\\reports\\2025-annual\\extracted\\02245634\\02245634.extraction.json" } } ], "announcement_id": "1422178", "status": "retrieved" }, { "source": "Nasdaq Nordic", "fetcher_build": "2026-08-03-nasdaq-cns-annual-period-v5.0.10", "retrieved_at": "2026-08-03T17:14:10Z", "company": "AstraZeneca PLC", "title": "Final Results", "category": "Financial Statement Release", "date": "2026-02-10", "language": "en", "report_type": "year-end-report", "fiscal_year": 2025, "quarter": "q4", "period": "2025-q4", "report_key": "2025:q4", "release_url": "https://view.news.eu.nasdaq.com/view?id=b9ce58d23cf2bde014b1c17b20cbd2186&lang=en&src=listed", "release_html_path": "D:\\Web\\aktieanalys\\data\\astrazeneca-plc\\nasdaq-reports\\reports\\2025-q4\\release.html", "release_text_path": "D:\\Web\\aktieanalys\\data\\astrazeneca-plc\\nasdaq-reports\\reports\\2025-q4\\release.txt", "attachments": [ { "label": "3233S.pdf", "url": "https://attachment.news.eu.nasdaq.com/a7944a29fd6a26422478fdc8ed671545d", "final_url": "https://attachment.news.eu.nasdaq.com/a7944a29fd6a26422478fdc8ed671545d", "filename": "3233S.pdf", "local_path": "D:\\Web\\aktieanalys\\data\\astrazeneca-plc\\nasdaq-reports\\reports\\2025-q4\\3233S.pdf", "content_type": "application/pdf", "size": 1252368, "sha256": "b74ab41a33cc73987ceaa462e95ea414aca5de066bd07f2fe21a0201e4a1be1c", "extraction": { "source_path": "D:\\Web\\aktieanalys\\data\\astrazeneca-plc\\nasdaq-reports\\reports\\2025-q4\\3233S.pdf", "filename": "3233S.pdf", "extension": ".pdf", "size": 1252368, "sha256": "b74ab41a33cc73987ceaa462e95ea414aca5de066bd07f2fe21a0201e4a1be1c", "status": "extracted", "text_path": "D:\\Web\\aktieanalys\\data\\astrazeneca-plc\\nasdaq-reports\\reports\\2025-q4\\extracted\\3233S\\3233S.txt", "text_chars": 125244, "metadata": { "page_count": 34, "empty_pages": 0, "encrypted": false }, "children": [], "warnings": [], "manifest_path": "D:\\Web\\aktieanalys\\data\\astrazeneca-plc\\nasdaq-reports\\reports\\2025-q4\\extracted\\3233S\\3233S.extraction.json" } }, { "label": "http://www.rns-pdf.londonstockexchange.com/rns/3227S_1-2026-2-9.pdf", "url": "http://www.rns-pdf.londonstockexchange.com/rns/3227S_1-2026-2-9.pdf", "final_url": "https://www.rns-pdf.londonstockexchange.com/rns/3227S_1-2026-2-9.pdf", "filename": "http_www.rns-pdf.londonstockexchange.com_rns_3227S_1-2026-2-9.pdf", "local_path": "D:\\Web\\aktieanalys\\data\\astrazeneca-plc\\nasdaq-reports\\reports\\2025-q4\\http_www.rns-pdf.londonstockexchange.com_rns_3227S_1-2026-2-9.pdf", "content_type": "application/pdf", "size": 1545942, "sha256": "568ede7aadd8f7e50cc4b6eec6922dc3c9fff855e49eaa2516093e79fe8ac679", "extraction": { "source_path": "D:\\Web\\aktieanalys\\data\\astrazeneca-plc\\nasdaq-reports\\reports\\2025-q4\\http_www.rns-pdf.londonstockexchange.com_rns_3227S_1-2026-2-9.pdf", "filename": "http_www.rns-pdf.londonstockexchange.com_rns_3227S_1-2026-2-9.pdf", "extension": ".pdf", "size": 1545942, "sha256": "568ede7aadd8f7e50cc4b6eec6922dc3c9fff855e49eaa2516093e79fe8ac679", "status": "extracted", "text_path": "D:\\Web\\aktieanalys\\data\\astrazeneca-plc\\nasdaq-reports\\reports\\2025-q4\\extracted\\http_www.rns-pdf.lon.com_rns_3227S_1-2026\\http_www.rns-pdf.londonst.com_rns_3227S_1-2026.txt", "text_chars": 138705, "metadata": { "page_count": 39, "empty_pages": 0, "encrypted": false }, "children": [], "warnings": [], "manifest_path": "D:\\Web\\aktieanalys\\data\\astrazeneca-plc\\nasdaq-reports\\reports\\2025-q4\\extracted\\http_www.rns-pdf.lon.com_rns_3227S_1-2026\\http_www.rns-pdf.londonst.com_rns_3227S_1-2026.extraction.json" } } ], "announcement_id": "1419083", "status": "retrieved" }, { "source": "Nasdaq Nordic", "fetcher_build": "2026-08-03-nasdaq-cns-annual-period-v5.0.10", "retrieved_at": "2026-08-03T17:14:19Z", "company": "AstraZeneca PLC", "title": "9M and Q3 2025 results", "category": "Interim report (Q1 and Q3)", "date": "2025-11-06", "language": "en", "report_type": "interim-report", "fiscal_year": 2025, "quarter": "q3", "period": "2025-q3", "report_key": "2025:q3", "release_url": "https://view.news.eu.nasdaq.com/view?id=b4aea0d8e933dd0ccac66c2e3be2b64d0&lang=en&src=listed", "release_html_path": "D:\\Web\\aktieanalys\\data\\astrazeneca-plc\\nasdaq-reports\\reports\\2025-q3\\release.html", "release_text_path": "D:\\Web\\aktieanalys\\data\\astrazeneca-plc\\nasdaq-reports\\reports\\2025-q3\\release.txt", "attachments": [ { "label": "11065940.pdf", "url": "https://attachment.news.eu.nasdaq.com/a6b0514be8a0eb722470815d6c48541c9", "final_url": "https://attachment.news.eu.nasdaq.com/a6b0514be8a0eb722470815d6c48541c9", "filename": "11065940.pdf", "local_path": "D:\\Web\\aktieanalys\\data\\astrazeneca-plc\\nasdaq-reports\\reports\\2025-q3\\11065940.pdf", "content_type": "application/pdf", "size": 1468577, "sha256": "de460cb4b01ef45d4df0b0a2bce97af47104fafef078983f3ecd5594fc0a97ad", "extraction": { "source_path": "D:\\Web\\aktieanalys\\data\\astrazeneca-plc\\nasdaq-reports\\reports\\2025-q3\\11065940.pdf", "filename": "11065940.pdf", "extension": ".pdf", "size": 1468577, "sha256": "de460cb4b01ef45d4df0b0a2bce97af47104fafef078983f3ecd5594fc0a97ad", "status": "extracted", "text_path": "D:\\Web\\aktieanalys\\data\\astrazeneca-plc\\nasdaq-reports\\reports\\2025-q3\\extracted\\11065940\\11065940.txt", "text_chars": 127823, "metadata": { "page_count": 39, "empty_pages": 0, "encrypted": false }, "children": [], "warnings": [], "manifest_path": "D:\\Web\\aktieanalys\\data\\astrazeneca-plc\\nasdaq-reports\\reports\\2025-q3\\extracted\\11065940\\11065940.extraction.json" } } ], "announcement_id": "1399073", "status": "retrieved" }, { "source": "Nasdaq Nordic", "fetcher_build": "2026-08-03-nasdaq-cns-annual-period-v5.0.10", "retrieved_at": "2026-08-03T17:14:38Z", "company": "AstraZeneca PLC", "title": "H1 and Q2 2025 results", "category": "Half Year financial report", "date": "2025-07-29", "language": "en", "report_type": "interim-report", "fiscal_year": 2025, "quarter": "q2", "period": "2025-q2", "report_key": "2025:q2", "release_url": "https://view.news.eu.nasdaq.com/view?id=b7ed7bd074a1dd53b1d4293bfab089e69&lang=en&src=listed", "release_html_path": "D:\\Web\\aktieanalys\\data\\astrazeneca-plc\\nasdaq-reports\\reports\\2025-q2\\release.html", "release_text_path": "D:\\Web\\aktieanalys\\data\\astrazeneca-plc\\nasdaq-reports\\reports\\2025-q2\\release.txt", "attachments": [ { "label": "H1 and Q2 2025 results.pdf", "url": "https://attachment.news.eu.nasdaq.com/ad088f09125d78d4ca4a8b44606420548", "final_url": "https://attachment.news.eu.nasdaq.com/ad088f09125d78d4ca4a8b44606420548", "filename": "H1_and_Q2_2025_results.pdf", "local_path": "D:\\Web\\aktieanalys\\data\\astrazeneca-plc\\nasdaq-reports\\reports\\2025-q2\\H1_and_Q2_2025_results.pdf", "content_type": "application/pdf", "size": 1537456, "sha256": "bccbf955cce93458737d6e0691237335077ee0ef556b18b9daa56e5495ddb466", "extraction": { "source_path": "D:\\Web\\aktieanalys\\data\\astrazeneca-plc\\nasdaq-reports\\reports\\2025-q2\\H1_and_Q2_2025_results.pdf", "filename": "H1_and_Q2_2025_results.pdf", "extension": ".pdf", "size": 1537456, "sha256": "bccbf955cce93458737d6e0691237335077ee0ef556b18b9daa56e5495ddb466", "status": "extracted", "text_path": "D:\\Web\\aktieanalys\\data\\astrazeneca-plc\\nasdaq-reports\\reports\\2025-q2\\extracted\\H1_and_Q2_2025_results\\H1_and_Q2_2025_results.txt", "text_chars": 144742, "metadata": { "page_count": 42, "empty_pages": 0, "encrypted": false }, "children": [], "warnings": [], "manifest_path": "D:\\Web\\aktieanalys\\data\\astrazeneca-plc\\nasdaq-reports\\reports\\2025-q2\\extracted\\H1_and_Q2_2025_results\\H1_and_Q2_2025_results.extraction.json" } }, { "label": "http://www.rns-pdf.londonstockexchange.com/rns/8920S_1-2025-7-28.pdf", "url": "http://www.rns-pdf.londonstockexchange.com/rns/8920S_1-2025-7-28.pdf", "final_url": "https://www.rns-pdf.londonstockexchange.com/rns/8920S_1-2025-7-28.pdf", "filename": "http_www.rns-pdf.londonstockexchange.com_rns_8920S_1-2025-7-28.pdf", "local_path": "D:\\Web\\aktieanalys\\data\\astrazeneca-plc\\nasdaq-reports\\reports\\2025-q2\\http_www.rns-pdf.londonstockexchange.com_rns_8920S_1-2025-7-28.pdf", "content_type": "application/pdf", "size": 1537456, "sha256": "bccbf955cce93458737d6e0691237335077ee0ef556b18b9daa56e5495ddb466", "extraction": { "source_path": "D:\\Web\\aktieanalys\\data\\astrazeneca-plc\\nasdaq-reports\\reports\\2025-q2\\http_www.rns-pdf.londonstockexchange.com_rns_8920S_1-2025-7-28.pdf", "filename": "http_www.rns-pdf.londonstockexchange.com_rns_8920S_1-2025-7-28.pdf", "extension": ".pdf", "size": 1537456, "sha256": "bccbf955cce93458737d6e0691237335077ee0ef556b18b9daa56e5495ddb466", "status": "extracted", "text_path": "D:\\Web\\aktieanalys\\data\\astrazeneca-plc\\nasdaq-reports\\reports\\2025-q2\\extracted\\http_www.rns-pdf.lo.com_rns_8920S_1-2025\\http_www.rns-pdf.londons.com_rns_8920S_1-2025.txt", "text_chars": 144742, "metadata": { "page_count": 42, "empty_pages": 0, "encrypted": false }, "children": [], "warnings": [], "manifest_path": "D:\\Web\\aktieanalys\\data\\astrazeneca-plc\\nasdaq-reports\\reports\\2025-q2\\extracted\\http_www.rns-pdf.lo.com_rns_8920S_1-2025\\http_www.rns-pdf.londons.com_rns_8920S_1-2025.extraction.json" } } ], "announcement_id": "1381080", "status": "retrieved" }, { "source": "Nasdaq Nordic", "fetcher_build": "2026-08-03-nasdaq-cns-annual-period-v5.0.10", "retrieved_at": "2026-08-03T17:14:54Z", "company": "AstraZeneca PLC", "title": "1st Quarter Results", "category": "Interim report (Q1 and Q3)", "date": "2025-04-29", "language": "en", "report_type": "interim-report", "fiscal_year": 2025, "quarter": "q1", "period": "2025-q1", "report_key": "2025:q1", "release_url": "https://view.news.eu.nasdaq.com/view?id=b18e7a2364eba4adf58e367470238a35b&lang=en&src=listed", "release_html_path": "D:\\Web\\aktieanalys\\data\\astrazeneca-plc\\nasdaq-reports\\reports\\2025-q1\\release.html", "release_text_path": "D:\\Web\\aktieanalys\\data\\astrazeneca-plc\\nasdaq-reports\\reports\\2025-q1\\release.txt", "attachments": [ { "label": "04294155.pdf", "url": "https://attachment.news.eu.nasdaq.com/aceea43c3a8d3a0d6df16bd92a6ff0bc6", "final_url": "https://attachment.news.eu.nasdaq.com/aceea43c3a8d3a0d6df16bd92a6ff0bc6", "filename": "04294155.pdf", "local_path": "D:\\Web\\aktieanalys\\data\\astrazeneca-plc\\nasdaq-reports\\reports\\2025-q1\\04294155.pdf", "content_type": "application/pdf", "size": 984678, "sha256": "24e40bba74661bdfda2252726f5d432768ab8195cc78150db849c00fd4e523dd", "extraction": { "source_path": "D:\\Web\\aktieanalys\\data\\astrazeneca-plc\\nasdaq-reports\\reports\\2025-q1\\04294155.pdf", "filename": "04294155.pdf", "extension": ".pdf", "size": 984678, "sha256": "24e40bba74661bdfda2252726f5d432768ab8195cc78150db849c00fd4e523dd", "status": "extracted", "text_path": "D:\\Web\\aktieanalys\\data\\astrazeneca-plc\\nasdaq-reports\\reports\\2025-q1\\extracted\\04294155\\04294155.txt", "text_chars": 119801, "metadata": { "page_count": 36, "empty_pages": 0, "encrypted": false }, "children": [], "warnings": [], "manifest_path": "D:\\Web\\aktieanalys\\data\\astrazeneca-plc\\nasdaq-reports\\reports\\2025-q1\\extracted\\04294155\\04294155.extraction.json" } }, { "label": "http://www.rns-pdf.londonstockexchange.com/rns/5152G_1-2025-4-28.pdf", "url": "http://www.rns-pdf.londonstockexchange.com/rns/5152G_1-2025-4-28.pdf", "final_url": "https://www.rns-pdf.londonstockexchange.com/rns/5152G_1-2025-4-28.pdf", "filename": "http_www.rns-pdf.londonstockexchange.com_rns_5152G_1-2025-4-28.pdf", "local_path": "D:\\Web\\aktieanalys\\data\\astrazeneca-plc\\nasdaq-reports\\reports\\2025-q1\\http_www.rns-pdf.londonstockexchange.com_rns_5152G_1-2025-4-28.pdf", "content_type": "application/pdf", "size": 984678, "sha256": "24e40bba74661bdfda2252726f5d432768ab8195cc78150db849c00fd4e523dd", "extraction": { "source_path": "D:\\Web\\aktieanalys\\data\\astrazeneca-plc\\nasdaq-reports\\reports\\2025-q1\\http_www.rns-pdf.londonstockexchange.com_rns_5152G_1-2025-4-28.pdf", "filename": "http_www.rns-pdf.londonstockexchange.com_rns_5152G_1-2025-4-28.pdf", "extension": ".pdf", "size": 984678, "sha256": "24e40bba74661bdfda2252726f5d432768ab8195cc78150db849c00fd4e523dd", "status": "extracted", "text_path": "D:\\Web\\aktieanalys\\data\\astrazeneca-plc\\nasdaq-reports\\reports\\2025-q1\\extracted\\http_www.rns-pdf.lo.com_rns_5152G_1-2025\\http_www.rns-pdf.londons.com_rns_5152G_1-2025.txt", "text_chars": 119801, "metadata": { "page_count": 36, "empty_pages": 0, "encrypted": false }, "children": [], "warnings": [], "manifest_path": "D:\\Web\\aktieanalys\\data\\astrazeneca-plc\\nasdaq-reports\\reports\\2025-q1\\extracted\\http_www.rns-pdf.lo.com_rns_5152G_1-2025\\http_www.rns-pdf.londons.com_rns_5152G_1-2025.extraction.json" } } ], "announcement_id": "1358987", "status": "retrieved" }, { "source": "Nasdaq Nordic", "fetcher_build": "2026-08-03-nasdaq-cns-annual-period-v5.0.10", "retrieved_at": "2026-08-03T17:14:54Z", "company": "AstraZeneca PLC", "title": "Annual Financial Report", "category": "Annual Financial Report", "date": "2025-02-18", "language": "en", "report_type": "annual-report", "fiscal_year": 2024, "quarter": "annual", "period": "2024-annual", "report_key": "2024:annual", "release_url": "https://view.news.eu.nasdaq.com/view?id=baa135dbe78c91b3922991707e9d4b7c1&lang=en&src=listed", "release_html_path": "D:\\Web\\aktieanalys\\data\\astrazeneca-plc\\nasdaq-reports\\reports\\2024-annual\\release.html", "release_text_path": "D:\\Web\\aktieanalys\\data\\astrazeneca-plc\\nasdaq-reports\\reports\\2024-annual\\release.txt", "attachments": [ { "label": "02188545.pdf", "url": "https://attachment.news.eu.nasdaq.com/ab50172710d60f24ca9c9d9f8ae3eddb3", "final_url": "https://attachment.news.eu.nasdaq.com/ab50172710d60f24ca9c9d9f8ae3eddb3", "filename": "02188545.pdf", "local_path": "D:\\Web\\aktieanalys\\data\\astrazeneca-plc\\nasdaq-reports\\reports\\2024-annual\\02188545.pdf", "content_type": "application/pdf", "size": 107129, "sha256": "6005163cf2b1f4e02004c48c7b56020ea7984bc886f4b099f1aa9387797c20fa", "extraction": { "source_path": "D:\\Web\\aktieanalys\\data\\astrazeneca-plc\\nasdaq-reports\\reports\\2024-annual\\02188545.pdf", "filename": "02188545.pdf", "extension": ".pdf", "size": 107129, "sha256": "6005163cf2b1f4e02004c48c7b56020ea7984bc886f4b099f1aa9387797c20fa", "status": "extracted", "text_path": "D:\\Web\\aktieanalys\\data\\astrazeneca-plc\\nasdaq-reports\\reports\\2024-annual\\extracted\\02188545\\02188545.txt", "text_chars": 2393, "metadata": { "page_count": 1, "empty_pages": 0, "encrypted": false }, "children": [], "warnings": [], "manifest_path": "D:\\Web\\aktieanalys\\data\\astrazeneca-plc\\nasdaq-reports\\reports\\2024-annual\\extracted\\02188545\\02188545.extraction.json" } } ], "announcement_id": "1343724", "status": "retrieved" }, { "source": "Nasdaq Nordic", "fetcher_build": "2026-08-03-nasdaq-cns-annual-period-v5.0.10", "retrieved_at": "2026-08-03T17:15:08Z", "company": "AstraZeneca PLC", "title": "9M and Q3 2024 Results", "category": "Interim report (Q1 and Q3)", "date": "2024-11-12", "language": "en", "report_type": "interim-report", "fiscal_year": 2024, "quarter": "q3", "period": "2024-q3", "report_key": "2024:q3", "release_url": "https://view.news.eu.nasdaq.com/view?id=b3046f86ab069a25d787d28291989e55c&lang=en&src=listed", "release_html_path": "D:\\Web\\aktieanalys\\data\\astrazeneca-plc\\nasdaq-reports\\reports\\2024-q3\\release.html", "release_text_path": "D:\\Web\\aktieanalys\\data\\astrazeneca-plc\\nasdaq-reports\\reports\\2024-q3\\release.txt", "attachments": [ { "label": "11125809.pdf", "url": "https://attachment.news.eu.nasdaq.com/a7d85580eb0dd41ae6cdf74ab1a011e2e", "final_url": "https://attachment.news.eu.nasdaq.com/a7d85580eb0dd41ae6cdf74ab1a011e2e", "filename": "11125809.pdf", "local_path": "D:\\Web\\aktieanalys\\data\\astrazeneca-plc\\nasdaq-reports\\reports\\2024-q3\\11125809.pdf", "content_type": "application/pdf", "size": 1130994, "sha256": "42cf108fb5d0339a59dc2451cf13694331a0eb6e135fdf48a0bc99e46e99e281", "extraction": { "source_path": "D:\\Web\\aktieanalys\\data\\astrazeneca-plc\\nasdaq-reports\\reports\\2024-q3\\11125809.pdf", "filename": "11125809.pdf", "extension": ".pdf", "size": 1130994, "sha256": "42cf108fb5d0339a59dc2451cf13694331a0eb6e135fdf48a0bc99e46e99e281", "status": "extracted", "text_path": "D:\\Web\\aktieanalys\\data\\astrazeneca-plc\\nasdaq-reports\\reports\\2024-q3\\extracted\\11125809\\11125809.txt", "text_chars": 137431, "metadata": { "page_count": 42, "empty_pages": 0, "encrypted": false }, "children": [], "warnings": [], "manifest_path": "D:\\Web\\aktieanalys\\data\\astrazeneca-plc\\nasdaq-reports\\reports\\2024-q3\\extracted\\11125809\\11125809.extraction.json" } } ], "announcement_id": "1327207", "status": "retrieved" }, { "source": "Nasdaq Nordic", "fetcher_build": "2026-08-03-nasdaq-cns-annual-period-v5.0.10", "retrieved_at": "2026-08-03T17:15:18Z", "company": "AstraZeneca PLC", "title": "Half-year Report", "category": "Half Year financial report", "date": "2024-07-25", "language": "en", "report_type": "interim-report", "fiscal_year": 2024, "quarter": "q2", "period": "2024-q2", "report_key": "2024:q2", "release_url": "https://view.news.eu.nasdaq.com/view?id=b18b8cfb1a23fdae62f030497b6a14b54&lang=en&src=listed", "release_html_path": "D:\\Web\\aktieanalys\\data\\astrazeneca-plc\\nasdaq-reports\\reports\\2024-q2\\release.html", "release_text_path": "D:\\Web\\aktieanalys\\data\\astrazeneca-plc\\nasdaq-reports\\reports\\2024-q2\\release.txt", "attachments": [ { "label": "07258987.pdf", "url": "https://attachment.news.eu.nasdaq.com/a9a9ed29bfd6832e30f8d5ad48b31be44", "final_url": "https://attachment.news.eu.nasdaq.com/a9a9ed29bfd6832e30f8d5ad48b31be44", "filename": "07258987.pdf", "local_path": "D:\\Web\\aktieanalys\\data\\astrazeneca-plc\\nasdaq-reports\\reports\\2024-q2\\07258987.pdf", "content_type": "application/pdf", "size": 4016695, "sha256": "e10f937783d2e317ed8d9ec7787f1ec1bd6eec0a1e670d13d4d7e774d999b947", "extraction": { "source_path": "D:\\Web\\aktieanalys\\data\\astrazeneca-plc\\nasdaq-reports\\reports\\2024-q2\\07258987.pdf", "filename": "07258987.pdf", "extension": ".pdf", "size": 4016695, "sha256": "e10f937783d2e317ed8d9ec7787f1ec1bd6eec0a1e670d13d4d7e774d999b947", "status": "extracted", "text_path": "D:\\Web\\aktieanalys\\data\\astrazeneca-plc\\nasdaq-reports\\reports\\2024-q2\\extracted\\07258987\\07258987.txt", "text_chars": 155942, "metadata": { "page_count": 42, "empty_pages": 0, "encrypted": false }, "children": [], "warnings": [], "manifest_path": "D:\\Web\\aktieanalys\\data\\astrazeneca-plc\\nasdaq-reports\\reports\\2024-q2\\extracted\\07258987\\07258987.extraction.json" } } ], "announcement_id": "1308013", "status": "retrieved" }, { "source": "Nasdaq Nordic", "fetcher_build": "2026-08-03-nasdaq-cns-annual-period-v5.0.10", "retrieved_at": "2026-08-03T17:15:19Z", "company": "AstraZeneca PLC", "title": "Annual Financial Report", "category": "Annual Financial Report", "date": "2024-02-20", "language": "en", "report_type": "annual-report", "fiscal_year": 2023, "quarter": "annual", "period": "2023-annual", "report_key": "2023:annual", "release_url": "https://view.news.eu.nasdaq.com/view?id=b888ddca0456c627907feb7996f4d70e7&lang=en&src=listed", "release_html_path": "D:\\Web\\aktieanalys\\data\\astrazeneca-plc\\nasdaq-reports\\reports\\2023-annual\\release.html", "release_text_path": "D:\\Web\\aktieanalys\\data\\astrazeneca-plc\\nasdaq-reports\\reports\\2023-annual\\release.txt", "attachments": [ { "label": "02201886.pdf", "url": "https://attachment.news.eu.nasdaq.com/aefd2ab38ab7fc19764b798b153be4f7d", "final_url": "https://attachment.news.eu.nasdaq.com/aefd2ab38ab7fc19764b798b153be4f7d", "filename": "02201886.pdf", "local_path": "D:\\Web\\aktieanalys\\data\\astrazeneca-plc\\nasdaq-reports\\reports\\2023-annual\\02201886.pdf", "content_type": "application/pdf", "size": 172970, "sha256": "c7a4fef5239d72026465eae25c5cce38739473ea26853573757bc43f4d2f0f75", "extraction": { "source_path": "D:\\Web\\aktieanalys\\data\\astrazeneca-plc\\nasdaq-reports\\reports\\2023-annual\\02201886.pdf", "filename": "02201886.pdf", "extension": ".pdf", "size": 172970, "sha256": "c7a4fef5239d72026465eae25c5cce38739473ea26853573757bc43f4d2f0f75", "status": "extracted", "text_path": "D:\\Web\\aktieanalys\\data\\astrazeneca-plc\\nasdaq-reports\\reports\\2023-annual\\extracted\\02201886\\02201886.txt", "text_chars": 2641, "metadata": { "page_count": 1, "empty_pages": 0, "encrypted": false }, "children": [], "warnings": [], "manifest_path": "D:\\Web\\aktieanalys\\data\\astrazeneca-plc\\nasdaq-reports\\reports\\2023-annual\\extracted\\02201886\\02201886.extraction.json" } } ], "announcement_id": "1276103", "status": "retrieved" }, { "source": "Nasdaq Nordic", "fetcher_build": "2026-08-03-nasdaq-cns-annual-period-v5.0.10", "retrieved_at": "2026-08-03T17:15:30Z", "company": "AstraZeneca PLC", "title": "9M and Q3 2023 results", "category": "Interim report (Q1 and Q3)", "date": "2023-11-09", "language": "en", "report_type": "interim-report", "fiscal_year": 2023, "quarter": "q3", "period": "2023-q3", "report_key": "2023:q3", "release_url": "https://view.news.eu.nasdaq.com/view?id=b9f7876ae92f1188ef2574bdc43934a95&lang=en&src=listed", "release_html_path": "D:\\Web\\aktieanalys\\data\\astrazeneca-plc\\nasdaq-reports\\reports\\2023-q3\\release.html", "release_text_path": "D:\\Web\\aktieanalys\\data\\astrazeneca-plc\\nasdaq-reports\\reports\\2023-q3\\release.txt", "attachments": [ { "label": "11091395.pdf", "url": "https://attachment.news.eu.nasdaq.com/a9fdf538c261c8884d36da766d1ac9718", "final_url": "https://attachment.news.eu.nasdaq.com/a9fdf538c261c8884d36da766d1ac9718", "filename": "11091395.pdf", "local_path": "D:\\Web\\aktieanalys\\data\\astrazeneca-plc\\nasdaq-reports\\reports\\2023-q3\\11091395.pdf", "content_type": "application/pdf", "size": 480764, "sha256": "bf9cb364e4c58495b8c5fe38fd83bcca98ce79007acfd745f1f5c9702aa68b12", "extraction": { "source_path": "D:\\Web\\aktieanalys\\data\\astrazeneca-plc\\nasdaq-reports\\reports\\2023-q3\\11091395.pdf", "filename": "11091395.pdf", "extension": ".pdf", "size": 480764, "sha256": "bf9cb364e4c58495b8c5fe38fd83bcca98ce79007acfd745f1f5c9702aa68b12", "status": "extracted", "text_path": "D:\\Web\\aktieanalys\\data\\astrazeneca-plc\\nasdaq-reports\\reports\\2023-q3\\extracted\\11091395\\11091395.txt", "text_chars": 149318, "metadata": { "page_count": 46, "empty_pages": 0, "encrypted": false }, "children": [], "warnings": [], "manifest_path": "D:\\Web\\aktieanalys\\data\\astrazeneca-plc\\nasdaq-reports\\reports\\2023-q3\\extracted\\11091395\\11091395.extraction.json" } } ], "announcement_id": "1258163", "status": "retrieved" }, { "source": "Nasdaq Nordic", "fetcher_build": "2026-08-03-nasdaq-cns-annual-period-v5.0.10", "retrieved_at": "2026-08-03T17:15:39Z", "company": "AstraZeneca PLC", "title": "Half-year Report", "category": "Half Year financial report", "date": "2023-07-28", "language": "en", "report_type": "interim-report", "fiscal_year": 2023, "quarter": "q2", "period": "2023-q2", "report_key": "2023:q2", "release_url": "https://view.news.eu.nasdaq.com/view?id=b7cf369050e9c05d1cc06a2df3c31169d&lang=en&src=listed", "release_html_path": "D:\\Web\\aktieanalys\\data\\astrazeneca-plc\\nasdaq-reports\\reports\\2023-q2\\release.html", "release_text_path": "D:\\Web\\aktieanalys\\data\\astrazeneca-plc\\nasdaq-reports\\reports\\2023-q2\\release.txt", "attachments": [ { "label": "07289280.pdf", "url": "https://attachment.news.eu.nasdaq.com/ab79b52fc3e3f6b753469465c818d7410", "final_url": "https://attachment.news.eu.nasdaq.com/ab79b52fc3e3f6b753469465c818d7410", "filename": "07289280.pdf", "local_path": "D:\\Web\\aktieanalys\\data\\astrazeneca-plc\\nasdaq-reports\\reports\\2023-q2\\07289280.pdf", "content_type": "application/pdf", "size": 1213703, "sha256": "f02f5f8ba9057106933d59b5005aa211b360551919be8f561e3c8b973a841a24", "extraction": { "source_path": "D:\\Web\\aktieanalys\\data\\astrazeneca-plc\\nasdaq-reports\\reports\\2023-q2\\07289280.pdf", "filename": "07289280.pdf", "extension": ".pdf", "size": 1213703, "sha256": "f02f5f8ba9057106933d59b5005aa211b360551919be8f561e3c8b973a841a24", "status": "extracted", "text_path": "D:\\Web\\aktieanalys\\data\\astrazeneca-plc\\nasdaq-reports\\reports\\2023-q2\\extracted\\07289280\\07289280.txt", "text_chars": 158635, "metadata": { "page_count": 48, "empty_pages": 0, "encrypted": false }, "children": [], "warnings": [], "manifest_path": "D:\\Web\\aktieanalys\\data\\astrazeneca-plc\\nasdaq-reports\\reports\\2023-q2\\extracted\\07289280\\07289280.extraction.json" } } ], "announcement_id": "1240330", "status": "retrieved" }, { "source": "Nasdaq Nordic", "fetcher_build": "2026-08-03-nasdaq-cns-annual-period-v5.0.10", "retrieved_at": "2026-08-03T17:15:40Z", "company": "AstraZeneca PLC", "title": "Block listing Interim Review", "category": "Interim report (Q1 and Q3)", "date": "2023-06-01", "language": "en", "report_type": "interim-report", "fiscal_year": 2023, "quarter": "q1", "period": "2023-q1", "report_key": "2023:q1", "release_url": "https://view.news.eu.nasdaq.com/view?id=b8d7dada127ea594d4193b469c12f001c&lang=en&src=listed", "release_html_path": "D:\\Web\\aktieanalys\\data\\astrazeneca-plc\\nasdaq-reports\\reports\\2023-q1\\release.html", "release_text_path": "D:\\Web\\aktieanalys\\data\\astrazeneca-plc\\nasdaq-reports\\reports\\2023-q1\\release.txt", "attachments": [ { "label": "06017034.pdf", "url": "https://attachment.news.eu.nasdaq.com/a032c58d210d62745c6d35441c52993b2", "final_url": "https://attachment.news.eu.nasdaq.com/a032c58d210d62745c6d35441c52993b2", "filename": "06017034.pdf", "local_path": "D:\\Web\\aktieanalys\\data\\astrazeneca-plc\\nasdaq-reports\\reports\\2023-q1\\06017034.pdf", "content_type": "application/pdf", "size": 228257, "sha256": "011c7d3ad087ef585142fcc7b59cc76e4831cf91ef22cc2479af54629cd16ce6", "extraction": { "source_path": "D:\\Web\\aktieanalys\\data\\astrazeneca-plc\\nasdaq-reports\\reports\\2023-q1\\06017034.pdf", "filename": "06017034.pdf", "extension": ".pdf", "size": 228257, "sha256": "011c7d3ad087ef585142fcc7b59cc76e4831cf91ef22cc2479af54629cd16ce6", "status": "extracted", "text_path": "D:\\Web\\aktieanalys\\data\\astrazeneca-plc\\nasdaq-reports\\reports\\2023-q1\\extracted\\06017034\\06017034.txt", "text_chars": 2351, "metadata": { "page_count": 2, "empty_pages": 0, "encrypted": false }, "children": [], "warnings": [], "manifest_path": "D:\\Web\\aktieanalys\\data\\astrazeneca-plc\\nasdaq-reports\\reports\\2023-q1\\extracted\\06017034\\06017034.extraction.json" } } ], "announcement_id": "1231639", "status": "retrieved" } ], "attempts": [ { "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=AstraZeneca&company=&market=&cnscategory=&fromDate=2023-01-01&toDate=&globalGroup=exchangeNotice&globalName=NordicMainMarkets&displayLanguage=sv&language=sv&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=0&dir=DESC", "status": 200, "scope": "NordicMainMarkets", "language": "sv", "start": 0, "pagination": "row-offset", "query_text": "AstraZeneca", "from_date": "2023-01-01", "to_date": "", "cache_tag": "broad", "rows": 100, "new_rows": 100, "total_count": null, "from_cache": false, "body_sha256": "a923a6440bfc1b0f1b4653fc0524b6e1ef154cb3adbf038092af698f8fb2806b" }, { "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=AstraZeneca&company=&market=&cnscategory=&fromDate=2023-01-01&toDate=&globalGroup=exchangeNotice&globalName=NordicMainMarkets&displayLanguage=sv&language=sv&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=100&dir=DESC", "status": 200, "scope": "NordicMainMarkets", "language": "sv", "start": 100, "pagination": "row-offset", "query_text": "AstraZeneca", "from_date": "2023-01-01", "to_date": "", "cache_tag": "broad", "rows": 100, "new_rows": 100, "total_count": null, "from_cache": false, "body_sha256": "adb2eb9f8694686399007d33ff5d9c77a41b15ce88e6751d31eca908adf34007" }, { "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=AstraZeneca&company=&market=&cnscategory=&fromDate=2023-01-01&toDate=&globalGroup=exchangeNotice&globalName=NordicMainMarkets&displayLanguage=sv&language=sv&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=200&dir=DESC", "status": 200, "scope": "NordicMainMarkets", "language": "sv", "start": 200, "pagination": "row-offset", "query_text": "AstraZeneca", "from_date": "2023-01-01", "to_date": "", "cache_tag": "broad", "rows": 100, "new_rows": 100, "total_count": null, "from_cache": false, "body_sha256": "cca9a1d89bf08eedaeab36db1451c2303001db15d1e93a513cf543786c5cec3f" }, { "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=AstraZeneca&company=&market=&cnscategory=&fromDate=2023-01-01&toDate=&globalGroup=exchangeNotice&globalName=NordicMainMarkets&displayLanguage=sv&language=sv&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=300&dir=DESC", "status": 200, "scope": "NordicMainMarkets", "language": "sv", "start": 300, "pagination": "row-offset", "query_text": "AstraZeneca", "from_date": "2023-01-01", "to_date": "", "cache_tag": "broad", "rows": 100, "new_rows": 100, "total_count": null, "from_cache": false, "body_sha256": "9b993bdcd1ee3fa763e90eb5dadd8cd247ac9522405f8e428f17a5038ae41d86" }, { "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=AstraZeneca&company=&market=&cnscategory=&fromDate=2023-01-01&toDate=&globalGroup=exchangeNotice&globalName=NordicMainMarkets&displayLanguage=sv&language=sv&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=400&dir=DESC", "status": 200, "scope": "NordicMainMarkets", "language": "sv", "start": 400, "pagination": "row-offset", "query_text": "AstraZeneca", "from_date": "2023-01-01", "to_date": "", "cache_tag": "broad", "rows": 100, "new_rows": 100, "total_count": null, "from_cache": false, "body_sha256": "f28c7a192c62a8f6d96b3f8466fb9546835cd3c45a3f32bad57b554ace496b9f" }, { "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=AstraZeneca&company=&market=&cnscategory=&fromDate=2023-01-01&toDate=&globalGroup=exchangeNotice&globalName=NordicMainMarkets&displayLanguage=sv&language=sv&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=500&dir=DESC", "status": 200, "scope": "NordicMainMarkets", "language": "sv", "start": 500, "pagination": "row-offset", "query_text": "AstraZeneca", "from_date": "2023-01-01", "to_date": "", "cache_tag": "broad", "rows": 100, "new_rows": 100, "total_count": null, "from_cache": false, "body_sha256": "3ad8c760cce677955d282a76efc6c2a2783e0e202aee31dc34e839da5107922c" }, { "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=AstraZeneca&company=&market=&cnscategory=&fromDate=2023-01-01&toDate=&globalGroup=exchangeNotice&globalName=NordicFirstNorth&displayLanguage=sv&language=sv&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=0&dir=DESC", "status": 200, "scope": "NordicFirstNorth", "language": "sv", "start": 0, "pagination": "row-offset", "query_text": "AstraZeneca", "from_date": "2023-01-01", "to_date": "", "cache_tag": "broad", "rows": 100, "new_rows": 100, "total_count": null, "from_cache": false, "body_sha256": "ef7aeb35012caa7c505b5dbd20c1d5c5f2baa2be245de4d74e08265681c2cff9" }, { "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=AstraZeneca&company=&market=&cnscategory=&fromDate=2023-01-01&toDate=&globalGroup=exchangeNotice&globalName=NordicFirstNorth&displayLanguage=sv&language=sv&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=100&dir=DESC", "status": 200, "scope": "NordicFirstNorth", "language": "sv", "start": 100, "pagination": "row-offset", "query_text": "AstraZeneca", "from_date": "2023-01-01", "to_date": "", "cache_tag": "broad", "rows": 100, "new_rows": 100, "total_count": null, "from_cache": false, "body_sha256": "7b392e3bfef5340a34297e6143c3a085c3355677e5f78bc48e99ac1867b3a692" }, { "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=AstraZeneca&company=&market=&cnscategory=&fromDate=2023-01-01&toDate=&globalGroup=exchangeNotice&globalName=NordicFirstNorth&displayLanguage=sv&language=sv&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=200&dir=DESC", "status": 200, "scope": "NordicFirstNorth", "language": "sv", "start": 200, "pagination": "row-offset", "query_text": "AstraZeneca", "from_date": "2023-01-01", "to_date": "", "cache_tag": "broad", "rows": 100, "new_rows": 100, "total_count": null, "from_cache": false, "body_sha256": "343f811203eacc1496797860a51e25f1b034dcf22bc2f58966ff9cf6d0c2c97e" }, { "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=AstraZeneca&company=&market=&cnscategory=&fromDate=2023-01-01&toDate=&globalGroup=exchangeNotice&globalName=NordicFirstNorth&displayLanguage=sv&language=sv&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=300&dir=DESC", "status": 200, "scope": "NordicFirstNorth", "language": "sv", "start": 300, "pagination": "row-offset", "query_text": "AstraZeneca", "from_date": "2023-01-01", "to_date": "", "cache_tag": "broad", "rows": 93, "new_rows": 93, "total_count": null, "from_cache": false, "body_sha256": "af6da2fe5bcf823bb99cce4d970440fa1c78d1389817fb79284e8f6ef1324763" }, { "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=AstraZeneca&company=&market=&cnscategory=&fromDate=2023-01-01&toDate=&globalGroup=exchangeNotice&globalName=NordicFirstNorth&displayLanguage=sv&language=sv&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=393&dir=DESC", "status": 200, "scope": "NordicFirstNorth", "language": "sv", "start": 393, "pagination": "row-offset", "query_text": "AstraZeneca", "from_date": "2023-01-01", "to_date": "", "cache_tag": "broad", "rows": 0, "new_rows": 0, "total_count": null, "from_cache": false, "body_sha256": "2fa6a83678d668b15cc706746b8a312f23c3e40d2cb2a78af9ee6dc911dedaac" }, { "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=AstraZeneca&company=&market=&cnscategory=&fromDate=2023-01-01&toDate=&globalGroup=&globalName=&displayLanguage=sv&language=sv&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=0&dir=DESC", "status": 200, "scope": "all-nordic", "language": "sv", "start": 0, "pagination": "row-offset", "query_text": "AstraZeneca", "from_date": "2023-01-01", "to_date": "", "cache_tag": "broad", "rows": 100, "new_rows": 100, "total_count": null, "from_cache": false, "body_sha256": "ba1146747bcc3e2be42349ef3f9c05cbfdba86e11a10c0d505a319f9490aed1d" }, { "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=AstraZeneca&company=&market=&cnscategory=&fromDate=2023-01-01&toDate=&globalGroup=&globalName=&displayLanguage=sv&language=sv&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=100&dir=DESC", "status": 200, "scope": "all-nordic", "language": "sv", "start": 100, "pagination": "row-offset", "query_text": "AstraZeneca", "from_date": "2023-01-01", "to_date": "", "cache_tag": "broad", "rows": 100, "new_rows": 100, "total_count": null, "from_cache": false, "body_sha256": "28a9c7defe4458c4430c7d20fe2c7a5736beeb3080457bedc399b0e49ebf9c26" }, { "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=AstraZeneca&company=&market=&cnscategory=&fromDate=2023-01-01&toDate=&globalGroup=&globalName=&displayLanguage=sv&language=sv&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=200&dir=DESC", "status": 200, "scope": "all-nordic", "language": "sv", "start": 200, "pagination": "row-offset", "query_text": "AstraZeneca", "from_date": "2023-01-01", "to_date": "", "cache_tag": "broad", "rows": 100, "new_rows": 100, "total_count": null, "from_cache": false, "body_sha256": "01e5d58679c33791e98424b733ae46fcfe0fc1f11be0ffeedd9dd43dc7adf115" }, { "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=AstraZeneca&company=&market=&cnscategory=&fromDate=2023-01-01&toDate=&globalGroup=&globalName=&displayLanguage=sv&language=sv&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=300&dir=DESC", "status": 200, "scope": "all-nordic", "language": "sv", "start": 300, "pagination": "row-offset", "query_text": "AstraZeneca", "from_date": "2023-01-01", "to_date": "", "cache_tag": "broad", "rows": 100, "new_rows": 100, "total_count": null, "from_cache": false, "body_sha256": "b01c3deba3b5322ee0f25e18faba00210935f15f7d13539736157b955239cdbc" }, { "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=AstraZeneca&company=&market=&cnscategory=&fromDate=2023-01-01&toDate=&globalGroup=&globalName=&displayLanguage=sv&language=sv&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=400&dir=DESC", "status": 200, "scope": "all-nordic", "language": "sv", "start": 400, "pagination": "row-offset", "query_text": "AstraZeneca", "from_date": "2023-01-01", "to_date": "", "cache_tag": "broad", "rows": 100, "new_rows": 100, "total_count": null, "from_cache": false, "body_sha256": "dd400547b28831f2fabf2e80731c73560977aa1cbc2d2838d05a19d806a34cf5" }, { "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=AstraZeneca&company=&market=&cnscategory=&fromDate=2023-01-01&toDate=&globalGroup=&globalName=&displayLanguage=sv&language=sv&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=500&dir=DESC", "status": 200, "scope": "all-nordic", "language": "sv", "start": 500, "pagination": "row-offset", "query_text": "AstraZeneca", "from_date": "2023-01-01", "to_date": "", "cache_tag": "broad", "rows": 100, "new_rows": 100, "total_count": null, "from_cache": false, "body_sha256": "ae59997c06596cab53184236d6b677cb8eb3acf3c72383990d5f481b2f9e9dbe" }, { "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=AstraZeneca&company=&market=&cnscategory=&fromDate=2023-01-01&toDate=&globalGroup=exchangeNotice&globalName=NordicMainMarkets&displayLanguage=en&language=en&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=0&dir=DESC", "status": 200, "scope": "NordicMainMarkets", "language": "en", "start": 0, "pagination": "row-offset", "query_text": "AstraZeneca", "from_date": "2023-01-01", "to_date": "", "cache_tag": "broad", "rows": 100, "new_rows": 100, "total_count": null, "from_cache": false, "body_sha256": "32baea5708ef2e222f85a4777c0aecdb179bbe1826bba09ada29d5130aa9bcb2" }, { "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=AstraZeneca&company=&market=&cnscategory=&fromDate=2023-01-01&toDate=&globalGroup=exchangeNotice&globalName=NordicMainMarkets&displayLanguage=en&language=en&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=100&dir=DESC", "status": 200, "scope": "NordicMainMarkets", "language": "en", "start": 100, "pagination": "row-offset", "query_text": "AstraZeneca", "from_date": "2023-01-01", "to_date": "", "cache_tag": "broad", "rows": 100, "new_rows": 100, "total_count": null, "from_cache": false, "body_sha256": "5392c18fe5dc6c8d509d72ecf65498514074c9e1805573ec78c26b402f9b9fea" }, { "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=AstraZeneca&company=&market=&cnscategory=&fromDate=2023-01-01&toDate=&globalGroup=exchangeNotice&globalName=NordicMainMarkets&displayLanguage=en&language=en&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=200&dir=DESC", "status": 200, "scope": "NordicMainMarkets", "language": "en", "start": 200, "pagination": "row-offset", "query_text": "AstraZeneca", "from_date": "2023-01-01", "to_date": "", "cache_tag": "broad", "rows": 100, "new_rows": 100, "total_count": null, "from_cache": false, "body_sha256": "972f95b99dc548b75f33c22e32328d0e8af177019a627b955d3d6919ac57029a" }, { "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=AstraZeneca&company=&market=&cnscategory=&fromDate=2023-01-01&toDate=&globalGroup=exchangeNotice&globalName=NordicMainMarkets&displayLanguage=en&language=en&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=300&dir=DESC", "status": 200, "scope": "NordicMainMarkets", "language": "en", "start": 300, "pagination": "row-offset", "query_text": "AstraZeneca", "from_date": "2023-01-01", "to_date": "", "cache_tag": "broad", "rows": 100, "new_rows": 100, "total_count": null, "from_cache": false, "body_sha256": "67b39a16809c9a6f055f9fcb3b3ebb9b04d76afe20ec336c3c609b1da3ff96fa" }, { "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=AstraZeneca&company=&market=&cnscategory=&fromDate=2023-01-01&toDate=&globalGroup=exchangeNotice&globalName=NordicMainMarkets&displayLanguage=en&language=en&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=400&dir=DESC", "status": 200, "scope": "NordicMainMarkets", "language": "en", "start": 400, "pagination": "row-offset", "query_text": "AstraZeneca", "from_date": "2023-01-01", "to_date": "", "cache_tag": "broad", "rows": 100, "new_rows": 100, "total_count": null, "from_cache": false, "body_sha256": "a9bf62fe6cf139e3671b8d1cec035d7a0bde9334a6dd6ed2b4600985dc786a72" }, { "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=AstraZeneca&company=&market=&cnscategory=&fromDate=2023-01-01&toDate=&globalGroup=exchangeNotice&globalName=NordicMainMarkets&displayLanguage=en&language=en&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=500&dir=DESC", "status": 200, "scope": "NordicMainMarkets", "language": "en", "start": 500, "pagination": "row-offset", "query_text": "AstraZeneca", "from_date": "2023-01-01", "to_date": "", "cache_tag": "broad", "rows": 100, "new_rows": 100, "total_count": null, "from_cache": false, "body_sha256": "d8e7559181eb7a848da635bca8ad8d1dfdf0498a1e3b360f1257752fd6dd3023" }, { "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=AstraZeneca&company=&market=&cnscategory=&fromDate=2023-01-01&toDate=&globalGroup=exchangeNotice&globalName=NordicFirstNorth&displayLanguage=en&language=en&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=0&dir=DESC", "status": 200, "scope": "NordicFirstNorth", "language": "en", "start": 0, "pagination": "row-offset", "query_text": "AstraZeneca", "from_date": "2023-01-01", "to_date": "", "cache_tag": "broad", "rows": 100, "new_rows": 100, "total_count": null, "from_cache": false, "body_sha256": "8255845e775e06437e67f2afce864af7b4a8dcdc55fc788f774428df2a455758" }, { "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=AstraZeneca&company=&market=&cnscategory=&fromDate=2023-01-01&toDate=&globalGroup=exchangeNotice&globalName=NordicFirstNorth&displayLanguage=en&language=en&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=100&dir=DESC", "status": 200, "scope": "NordicFirstNorth", "language": "en", "start": 100, "pagination": "row-offset", "query_text": "AstraZeneca", "from_date": "2023-01-01", "to_date": "", "cache_tag": "broad", "rows": 100, "new_rows": 100, "total_count": null, "from_cache": false, "body_sha256": "b914d9c3388f5a39e5f3933ae5c0d97903095ab5a95b0d04b871869a6f1fcc05" }, { "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=AstraZeneca&company=&market=&cnscategory=&fromDate=2023-01-01&toDate=&globalGroup=exchangeNotice&globalName=NordicFirstNorth&displayLanguage=en&language=en&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=200&dir=DESC", "status": 200, "scope": "NordicFirstNorth", "language": "en", "start": 200, "pagination": "row-offset", "query_text": "AstraZeneca", "from_date": "2023-01-01", "to_date": "", "cache_tag": "broad", "rows": 88, "new_rows": 88, "total_count": null, "from_cache": false, "body_sha256": "1791a59b5ceef387a982840f07242b44d1e49666d607345cbc291eca113f9cef" }, { "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=AstraZeneca&company=&market=&cnscategory=&fromDate=2023-01-01&toDate=&globalGroup=exchangeNotice&globalName=NordicFirstNorth&displayLanguage=en&language=en&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=288&dir=DESC", "status": 200, "scope": "NordicFirstNorth", "language": "en", "start": 288, "pagination": "row-offset", "query_text": "AstraZeneca", "from_date": "2023-01-01", "to_date": "", "cache_tag": "broad", "rows": 0, "new_rows": 0, "total_count": null, "from_cache": false, "body_sha256": "86441dbd23cdff3619f0dac48b691ae7cd96453f8dd9966beff5e93a56e2a047" }, { "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=AstraZeneca&company=&market=&cnscategory=&fromDate=2024-03-01&toDate=2024-06-15&globalGroup=exchangeNotice&globalName=NordicMainMarkets&displayLanguage=sv&language=sv&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=0&dir=DESC", "status": 200, "scope": "NordicMainMarkets", "language": "sv", "start": 0, "pagination": "row-offset", "query_text": "AstraZeneca", "from_date": "2024-03-01", "to_date": "2024-06-15", "cache_tag": "recover-2024-q1", "rows": 100, "new_rows": 100, "total_count": null, "from_cache": false, "body_sha256": "a923a6440bfc1b0f1b4653fc0524b6e1ef154cb3adbf038092af698f8fb2806b", "recovery_target": "2024:q1" }, { "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=AstraZeneca&company=&market=&cnscategory=&fromDate=2024-03-01&toDate=2024-06-15&globalGroup=exchangeNotice&globalName=NordicMainMarkets&displayLanguage=sv&language=sv&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=100&dir=DESC", "status": 200, "scope": "NordicMainMarkets", "language": "sv", "start": 100, "pagination": "row-offset", "query_text": "AstraZeneca", "from_date": "2024-03-01", "to_date": "2024-06-15", "cache_tag": "recover-2024-q1", "rows": 100, "new_rows": 100, "total_count": null, "from_cache": false, "body_sha256": "adb2eb9f8694686399007d33ff5d9c77a41b15ce88e6751d31eca908adf34007", "recovery_target": "2024:q1" }, { "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=AstraZeneca&company=&market=&cnscategory=&fromDate=2024-03-01&toDate=2024-06-15&globalGroup=exchangeNotice&globalName=NordicFirstNorth&displayLanguage=sv&language=sv&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=0&dir=DESC", "status": 200, "scope": "NordicFirstNorth", "language": "sv", "start": 0, "pagination": "row-offset", "query_text": "AstraZeneca", "from_date": "2024-03-01", "to_date": "2024-06-15", "cache_tag": "recover-2024-q1", "rows": 100, "new_rows": 100, "total_count": null, "from_cache": false, "body_sha256": "ef7aeb35012caa7c505b5dbd20c1d5c5f2baa2be245de4d74e08265681c2cff9", "recovery_target": "2024:q1" }, { "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=AstraZeneca&company=&market=&cnscategory=&fromDate=2024-03-01&toDate=2024-06-15&globalGroup=exchangeNotice&globalName=NordicFirstNorth&displayLanguage=sv&language=sv&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=100&dir=DESC", "status": 200, "scope": "NordicFirstNorth", "language": "sv", "start": 100, "pagination": "row-offset", "query_text": "AstraZeneca", "from_date": "2024-03-01", "to_date": "2024-06-15", "cache_tag": "recover-2024-q1", "rows": 100, "new_rows": 100, "total_count": null, "from_cache": false, "body_sha256": "7b392e3bfef5340a34297e6143c3a085c3355677e5f78bc48e99ac1867b3a692", "recovery_target": "2024:q1" }, { "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=AstraZeneca&company=&market=&cnscategory=&fromDate=2024-03-01&toDate=2024-06-15&globalGroup=&globalName=&displayLanguage=sv&language=sv&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=0&dir=DESC", "status": 200, "scope": "all-nordic", "language": "sv", "start": 0, "pagination": "row-offset", "query_text": "AstraZeneca", "from_date": "2024-03-01", "to_date": "2024-06-15", "cache_tag": "recover-2024-q1", "rows": 100, "new_rows": 100, "total_count": null, "from_cache": false, "body_sha256": "ba1146747bcc3e2be42349ef3f9c05cbfdba86e11a10c0d505a319f9490aed1d", "recovery_target": "2024:q1" }, { "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=AstraZeneca&company=&market=&cnscategory=&fromDate=2024-03-01&toDate=2024-06-15&globalGroup=&globalName=&displayLanguage=sv&language=sv&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=100&dir=DESC", "status": 200, "scope": "all-nordic", "language": "sv", "start": 100, "pagination": "row-offset", "query_text": "AstraZeneca", "from_date": "2024-03-01", "to_date": "2024-06-15", "cache_tag": "recover-2024-q1", "rows": 100, "new_rows": 100, "total_count": null, "from_cache": false, "body_sha256": "28a9c7defe4458c4430c7d20fe2c7a5736beeb3080457bedc399b0e49ebf9c26", "recovery_target": "2024:q1" }, { "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=AstraZeneca&company=&market=&cnscategory=&fromDate=2024-03-01&toDate=2024-06-15&globalGroup=exchangeNotice&globalName=NordicMainMarkets&displayLanguage=en&language=en&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=0&dir=DESC", "status": 200, "scope": "NordicMainMarkets", "language": "en", "start": 0, "pagination": "row-offset", "query_text": "AstraZeneca", "from_date": "2024-03-01", "to_date": "2024-06-15", "cache_tag": "recover-2024-q1", "rows": 100, "new_rows": 100, "total_count": null, "from_cache": false, "body_sha256": "32baea5708ef2e222f85a4777c0aecdb179bbe1826bba09ada29d5130aa9bcb2", "recovery_target": "2024:q1" }, { "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=AstraZeneca&company=&market=&cnscategory=&fromDate=2024-03-01&toDate=2024-06-15&globalGroup=exchangeNotice&globalName=NordicMainMarkets&displayLanguage=en&language=en&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=100&dir=DESC", "status": 200, "scope": "NordicMainMarkets", "language": "en", "start": 100, "pagination": "row-offset", "query_text": "AstraZeneca", "from_date": "2024-03-01", "to_date": "2024-06-15", "cache_tag": "recover-2024-q1", "rows": 100, "new_rows": 100, "total_count": null, "from_cache": false, "body_sha256": "5392c18fe5dc6c8d509d72ecf65498514074c9e1805573ec78c26b402f9b9fea", "recovery_target": "2024:q1" }, { "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=AstraZeneca&company=&market=&cnscategory=&fromDate=2024-03-01&toDate=2024-06-15&globalGroup=exchangeNotice&globalName=NordicFirstNorth&displayLanguage=en&language=en&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=0&dir=DESC", "status": 200, "scope": "NordicFirstNorth", "language": "en", "start": 0, "pagination": "row-offset", "query_text": "AstraZeneca", "from_date": "2024-03-01", "to_date": "2024-06-15", "cache_tag": "recover-2024-q1", "rows": 100, "new_rows": 100, "total_count": null, "from_cache": false, "body_sha256": "8255845e775e06437e67f2afce864af7b4a8dcdc55fc788f774428df2a455758", "recovery_target": "2024:q1" }, { "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=AstraZeneca&company=&market=&cnscategory=&fromDate=2024-03-01&toDate=2024-06-15&globalGroup=exchangeNotice&globalName=NordicFirstNorth&displayLanguage=en&language=en&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=100&dir=DESC", "status": 200, "scope": "NordicFirstNorth", "language": "en", "start": 100, "pagination": "row-offset", "query_text": "AstraZeneca", "from_date": "2024-03-01", "to_date": "2024-06-15", "cache_tag": "recover-2024-q1", "rows": 100, "new_rows": 100, "total_count": null, "from_cache": false, "body_sha256": "b914d9c3388f5a39e5f3933ae5c0d97903095ab5a95b0d04b871869a6f1fcc05", "recovery_target": "2024:q1" }, { "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=AstraZeneca&company=&market=&cnscategory=&fromDate=2024-03-01&toDate=2024-06-15&globalGroup=&globalName=&displayLanguage=en&language=en&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=0&dir=DESC", "status": 200, "scope": "all-nordic", "language": "en", "start": 0, "pagination": "row-offset", "query_text": "AstraZeneca", "from_date": "2024-03-01", "to_date": "2024-06-15", "cache_tag": "recover-2024-q1", "rows": 100, "new_rows": 100, "total_count": null, "from_cache": false, "body_sha256": "c6e3317a54529292bc9000d917b0cfaa770b2b1caf56add2098d1d969bb6de1d", "recovery_target": "2024:q1" }, { "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=AstraZeneca&company=&market=&cnscategory=&fromDate=2024-03-01&toDate=2024-06-15&globalGroup=&globalName=&displayLanguage=en&language=en&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=100&dir=DESC", "status": 200, "scope": "all-nordic", "language": "en", "start": 100, "pagination": "row-offset", "query_text": "AstraZeneca", "from_date": "2024-03-01", "to_date": "2024-06-15", "cache_tag": "recover-2024-q1", "rows": 100, "new_rows": 100, "total_count": null, "from_cache": false, "body_sha256": "53a9266d7080cd569a0ca5be5ec2b09673e6aa28090f9a1ec1c5a0de404a100a", "recovery_target": "2024:q1" }, { "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=AstraZeneca+PLC&company=&market=&cnscategory=&fromDate=2024-03-01&toDate=2024-06-15&globalGroup=exchangeNotice&globalName=NordicMainMarkets&displayLanguage=sv&language=sv&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=0&dir=DESC", "status": 200, "scope": "NordicMainMarkets", "language": "sv", "start": 0, "pagination": "row-offset", "query_text": "AstraZeneca PLC", "from_date": "2024-03-01", "to_date": "2024-06-15", "cache_tag": "recover-2024-q1", "rows": 100, "new_rows": 100, "total_count": null, "from_cache": false, "body_sha256": "2ce708a6b7c37bae2fb4b5f032d3ca0c1bd8374ec7133ccff6279a0e4287724f", "recovery_target": "2024:q1" }, { "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=AstraZeneca+PLC&company=&market=&cnscategory=&fromDate=2024-03-01&toDate=2024-06-15&globalGroup=exchangeNotice&globalName=NordicMainMarkets&displayLanguage=sv&language=sv&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=100&dir=DESC", "status": 200, "scope": "NordicMainMarkets", "language": "sv", "start": 100, "pagination": "row-offset", "query_text": "AstraZeneca PLC", "from_date": "2024-03-01", "to_date": "2024-06-15", "cache_tag": "recover-2024-q1", "rows": 46, "new_rows": 46, "total_count": null, "from_cache": false, "body_sha256": "c6922bd6f4f9f98746fb7ff8289dc618a908846d6e4dcf8b20671570cb257b12", "recovery_target": "2024:q1" }, { "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=AstraZeneca+PLC&company=&market=&cnscategory=&fromDate=2024-03-01&toDate=2024-06-15&globalGroup=exchangeNotice&globalName=NordicFirstNorth&displayLanguage=sv&language=sv&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=0&dir=DESC", "status": 200, "scope": "NordicFirstNorth", "language": "sv", "start": 0, "pagination": "row-offset", "query_text": "AstraZeneca PLC", "from_date": "2024-03-01", "to_date": "2024-06-15", "cache_tag": "recover-2024-q1", "rows": 5, "new_rows": 5, "total_count": null, "from_cache": false, "body_sha256": "298e21c8831a79febc7c131e5e7f214bac032d3d32c0954b4d4c698f6fa32c6c", "recovery_target": "2024:q1" }, { "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=AstraZeneca+PLC&company=&market=&cnscategory=&fromDate=2024-03-01&toDate=2024-06-15&globalGroup=exchangeNotice&globalName=NordicFirstNorth&displayLanguage=sv&language=sv&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=5&dir=DESC", "status": 200, "scope": "NordicFirstNorth", "language": "sv", "start": 5, "pagination": "row-offset", "query_text": "AstraZeneca PLC", "from_date": "2024-03-01", "to_date": "2024-06-15", "cache_tag": "recover-2024-q1", "rows": 0, "new_rows": 0, "total_count": null, "from_cache": false, "body_sha256": "d97ee824ab5793095b25a383238d191f6e98476d65197a4c886f360e00a0680f", "recovery_target": "2024:q1" }, { "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=AstraZeneca+PLC&company=&market=&cnscategory=&fromDate=2024-03-01&toDate=2024-06-15&globalGroup=&globalName=&displayLanguage=sv&language=sv&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=0&dir=DESC", "status": 200, "scope": "all-nordic", "language": "sv", "start": 0, "pagination": "row-offset", "query_text": "AstraZeneca PLC", "from_date": "2024-03-01", "to_date": "2024-06-15", "cache_tag": "recover-2024-q1", "rows": 100, "new_rows": 100, "total_count": null, "from_cache": false, "body_sha256": "a530717ed48e62a6bac225873b6d26ae09e60fa5296efa3baa4b828f81e2f4a3", "recovery_target": "2024:q1" }, { "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=AstraZeneca+PLC&company=&market=&cnscategory=&fromDate=2024-03-01&toDate=2024-06-15&globalGroup=&globalName=&displayLanguage=sv&language=sv&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=100&dir=DESC", "status": 200, "scope": "all-nordic", "language": "sv", "start": 100, "pagination": "row-offset", "query_text": "AstraZeneca PLC", "from_date": "2024-03-01", "to_date": "2024-06-15", "cache_tag": "recover-2024-q1", "rows": 56, "new_rows": 56, "total_count": null, "from_cache": false, "body_sha256": "60a87d43eff1912ee5fa2d7c6544b184b55b0d75ea369f3fb26921a4fe8f2218", "recovery_target": "2024:q1" }, { "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=AstraZeneca+PLC&company=&market=&cnscategory=&fromDate=2024-03-01&toDate=2024-06-15&globalGroup=exchangeNotice&globalName=NordicMainMarkets&displayLanguage=en&language=en&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=0&dir=DESC", "status": 200, "scope": "NordicMainMarkets", "language": "en", "start": 0, "pagination": "row-offset", "query_text": "AstraZeneca PLC", "from_date": "2024-03-01", "to_date": "2024-06-15", "cache_tag": "recover-2024-q1", "rows": 100, "new_rows": 100, "total_count": null, "from_cache": false, "body_sha256": "f6d16bdd76c3c72f926efa77ef50237b9477d4ead3d93815a9018d0f8d5dfc10", "recovery_target": "2024:q1" }, { "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=AstraZeneca+PLC&company=&market=&cnscategory=&fromDate=2024-03-01&toDate=2024-06-15&globalGroup=exchangeNotice&globalName=NordicMainMarkets&displayLanguage=en&language=en&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=100&dir=DESC", "status": 200, "scope": "NordicMainMarkets", "language": "en", "start": 100, "pagination": "row-offset", "query_text": "AstraZeneca PLC", "from_date": "2024-03-01", "to_date": "2024-06-15", "cache_tag": "recover-2024-q1", "rows": 100, "new_rows": 100, "total_count": null, "from_cache": false, "body_sha256": "94dc2832ade5d1327a0e8a21a9a828795d60191876179a36f64461840f65d93b", "recovery_target": "2024:q1" }, { "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=AstraZeneca+PLC&company=&market=&cnscategory=&fromDate=2024-03-01&toDate=2024-06-15&globalGroup=exchangeNotice&globalName=NordicFirstNorth&displayLanguage=en&language=en&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=0&dir=DESC", "status": 200, "scope": "NordicFirstNorth", "language": "en", "start": 0, "pagination": "row-offset", "query_text": "AstraZeneca PLC", "from_date": "2024-03-01", "to_date": "2024-06-15", "cache_tag": "recover-2024-q1", "rows": 20, "new_rows": 20, "total_count": null, "from_cache": false, "body_sha256": "3ed1f733125ecd37dc605bab5297eaa5378c4cf095bfad501b755d1d7eb0db47", "recovery_target": "2024:q1" }, { "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=AstraZeneca+PLC&company=&market=&cnscategory=&fromDate=2024-03-01&toDate=2024-06-15&globalGroup=exchangeNotice&globalName=NordicFirstNorth&displayLanguage=en&language=en&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=20&dir=DESC", "status": 200, "scope": "NordicFirstNorth", "language": "en", "start": 20, "pagination": "row-offset", "query_text": "AstraZeneca PLC", "from_date": "2024-03-01", "to_date": "2024-06-15", "cache_tag": "recover-2024-q1", "rows": 0, "new_rows": 0, "total_count": null, "from_cache": false, "body_sha256": "803ed10fffb20bfbee34f8b769a0dacd60feb1d18deb9696a58342afe8501843", "recovery_target": "2024:q1" }, { "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=AstraZeneca+PLC&company=&market=&cnscategory=&fromDate=2024-03-01&toDate=2024-06-15&globalGroup=&globalName=&displayLanguage=en&language=en&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=0&dir=DESC", "status": 200, "scope": "all-nordic", "language": "en", "start": 0, "pagination": "row-offset", "query_text": "AstraZeneca PLC", "from_date": "2024-03-01", "to_date": "2024-06-15", "cache_tag": "recover-2024-q1", "rows": 100, "new_rows": 100, "total_count": null, "from_cache": false, "body_sha256": "af48ec5e0a262b181571e09da3e58581befba851421ae18075bab88fa40badde", "recovery_target": "2024:q1" }, { "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=AstraZeneca+PLC&company=&market=&cnscategory=&fromDate=2024-03-01&toDate=2024-06-15&globalGroup=&globalName=&displayLanguage=en&language=en&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=100&dir=DESC", "status": 200, "scope": "all-nordic", "language": "en", "start": 100, "pagination": "row-offset", "query_text": "AstraZeneca PLC", "from_date": "2024-03-01", "to_date": "2024-06-15", "cache_tag": "recover-2024-q1", "rows": 100, "new_rows": 100, "total_count": null, "from_cache": false, "body_sha256": "ef7b60f9eb99d67c0024bb5d26ab48e3cd70ae0df67737c2305d9536f53d15eb", "recovery_target": "2024:q1" }, { "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=Avanza+Bank+AB&company=&market=&cnscategory=&fromDate=2024-03-01&toDate=2024-06-15&globalGroup=exchangeNotice&globalName=NordicMainMarkets&displayLanguage=sv&language=sv&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=0&dir=DESC", "status": 200, "scope": "NordicMainMarkets", "language": "sv", "start": 0, "pagination": "row-offset", "query_text": "Avanza Bank AB", "from_date": "2024-03-01", "to_date": "2024-06-15", "cache_tag": "recover-2024-q1", "rows": 100, "new_rows": 100, "total_count": null, "from_cache": false, "body_sha256": "edd365418b34b26acc1105d9d4e100749bade5a5f22c7954c2999a993d3747de", "recovery_target": "2024:q1" }, { "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=Avanza+Bank+AB&company=&market=&cnscategory=&fromDate=2024-03-01&toDate=2024-06-15&globalGroup=exchangeNotice&globalName=NordicMainMarkets&displayLanguage=sv&language=sv&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=100&dir=DESC", "status": 200, "scope": "NordicMainMarkets", "language": "sv", "start": 100, "pagination": "row-offset", "query_text": "Avanza Bank AB", "from_date": "2024-03-01", "to_date": "2024-06-15", "cache_tag": "recover-2024-q1", "rows": 100, "new_rows": 100, "total_count": null, "from_cache": false, "body_sha256": "ec097721b075c0174a8403e872b59eb48ac4c93f6f96d780874958103facf535", "recovery_target": "2024:q1" }, { "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=Avanza+Bank+AB&company=&market=&cnscategory=&fromDate=2024-03-01&toDate=2024-06-15&globalGroup=exchangeNotice&globalName=NordicFirstNorth&displayLanguage=sv&language=sv&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=0&dir=DESC", "status": 200, "scope": "NordicFirstNorth", "language": "sv", "start": 0, "pagination": "row-offset", "query_text": "Avanza Bank AB", "from_date": "2024-03-01", "to_date": "2024-06-15", "cache_tag": "recover-2024-q1", "rows": 100, "new_rows": 100, "total_count": null, "from_cache": false, "body_sha256": "2acc13b88ebcf418e3821f68817da853a3b95aa765f683c59c7af873eea59726", "recovery_target": "2024:q1" }, { "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=Avanza+Bank+AB&company=&market=&cnscategory=&fromDate=2024-03-01&toDate=2024-06-15&globalGroup=exchangeNotice&globalName=NordicFirstNorth&displayLanguage=sv&language=sv&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=100&dir=DESC", "status": 200, "scope": "NordicFirstNorth", "language": "sv", "start": 100, "pagination": "row-offset", "query_text": "Avanza Bank AB", "from_date": "2024-03-01", "to_date": "2024-06-15", "cache_tag": "recover-2024-q1", "rows": 100, "new_rows": 100, "total_count": null, "from_cache": false, "body_sha256": "be73de330edcf319dad38801228fe1805a17fdc3138a40408bfc5c53fc5e3119", "recovery_target": "2024:q1" }, { "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=Avanza+Bank+AB&company=&market=&cnscategory=&fromDate=2024-03-01&toDate=2024-06-15&globalGroup=&globalName=&displayLanguage=sv&language=sv&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=0&dir=DESC", "status": 200, "scope": "all-nordic", "language": "sv", "start": 0, "pagination": "row-offset", "query_text": "Avanza Bank AB", "from_date": "2024-03-01", "to_date": "2024-06-15", "cache_tag": "recover-2024-q1", "rows": 100, "new_rows": 100, "total_count": null, "from_cache": false, "body_sha256": "cfce31c1243e2265745583596ff693c516e2fa2ad78164971487fd6e5d776792", "recovery_target": "2024:q1" }, { "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=Avanza+Bank+AB&company=&market=&cnscategory=&fromDate=2024-03-01&toDate=2024-06-15&globalGroup=&globalName=&displayLanguage=sv&language=sv&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=100&dir=DESC", "status": 200, "scope": "all-nordic", "language": "sv", "start": 100, "pagination": "row-offset", "query_text": "Avanza Bank AB", "from_date": "2024-03-01", "to_date": "2024-06-15", "cache_tag": "recover-2024-q1", "rows": 100, "new_rows": 100, "total_count": null, "from_cache": false, "body_sha256": "16d4b32d75a7f113481b8c90db1650dcf4f2dafd6f5fe2ee337af480505f8eb6", "recovery_target": "2024:q1" }, { "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=Avanza+Bank+AB&company=&market=&cnscategory=&fromDate=2024-03-01&toDate=2024-06-15&globalGroup=exchangeNotice&globalName=NordicMainMarkets&displayLanguage=en&language=en&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=0&dir=DESC", "status": 200, "scope": "NordicMainMarkets", "language": "en", "start": 0, "pagination": "row-offset", "query_text": "Avanza Bank AB", "from_date": "2024-03-01", "to_date": "2024-06-15", "cache_tag": "recover-2024-q1", "rows": 100, "new_rows": 100, "total_count": null, "from_cache": false, "body_sha256": "7066f8c7d4d0f7678e61eac768e6d40652ba5b15e1438b644d29f4b6493f5c74", "recovery_target": "2024:q1" }, { "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=Avanza+Bank+AB&company=&market=&cnscategory=&fromDate=2024-03-01&toDate=2024-06-15&globalGroup=exchangeNotice&globalName=NordicMainMarkets&displayLanguage=en&language=en&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=100&dir=DESC", "status": 200, "scope": "NordicMainMarkets", "language": "en", "start": 100, "pagination": "row-offset", "query_text": "Avanza Bank AB", "from_date": "2024-03-01", "to_date": "2024-06-15", "cache_tag": "recover-2024-q1", "rows": 100, "new_rows": 100, "total_count": null, "from_cache": false, "body_sha256": "bce8ec78dbab559876e12728dc879c302511554964955c621398e22ba67cb6e0", "recovery_target": "2024:q1" }, { "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=Avanza+Bank+AB&company=&market=&cnscategory=&fromDate=2024-03-01&toDate=2024-06-15&globalGroup=exchangeNotice&globalName=NordicFirstNorth&displayLanguage=en&language=en&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=0&dir=DESC", "status": 200, "scope": "NordicFirstNorth", "language": "en", "start": 0, "pagination": "row-offset", "query_text": "Avanza Bank AB", "from_date": "2024-03-01", "to_date": "2024-06-15", "cache_tag": "recover-2024-q1", "rows": 100, "new_rows": 100, "total_count": null, "from_cache": false, "body_sha256": "16d6f36fb5abc6158d9ebfe98feb900bf9dff3e78d596ed82eb39678adfcbe5c", "recovery_target": "2024:q1" }, { "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=Avanza+Bank+AB&company=&market=&cnscategory=&fromDate=2024-03-01&toDate=2024-06-15&globalGroup=exchangeNotice&globalName=NordicFirstNorth&displayLanguage=en&language=en&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=100&dir=DESC", "status": 200, "scope": "NordicFirstNorth", "language": "en", "start": 100, "pagination": "row-offset", "query_text": "Avanza Bank AB", "from_date": "2024-03-01", "to_date": "2024-06-15", "cache_tag": "recover-2024-q1", "rows": 100, "new_rows": 100, "total_count": null, "from_cache": false, "body_sha256": "e9a64e8199def3db60c24f14897b63ab51ced87b9e91942f66703e27b6b8aacf", "recovery_target": "2024:q1" }, { "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=Avanza+Bank+AB&company=&market=&cnscategory=&fromDate=2024-03-01&toDate=2024-06-15&globalGroup=&globalName=&displayLanguage=en&language=en&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=0&dir=DESC", "status": 200, "scope": "all-nordic", "language": "en", "start": 0, "pagination": "row-offset", "query_text": "Avanza Bank AB", "from_date": "2024-03-01", "to_date": "2024-06-15", "cache_tag": "recover-2024-q1", "rows": 100, "new_rows": 100, "total_count": null, "from_cache": false, "body_sha256": "f4b5fbb8ba248d5463ff465f7ad3ab248382e1ca567429da8c1d81596d42f87a", "recovery_target": "2024:q1" }, { "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=Avanza+Bank+AB&company=&market=&cnscategory=&fromDate=2024-03-01&toDate=2024-06-15&globalGroup=&globalName=&displayLanguage=en&language=en&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=100&dir=DESC", "status": 200, "scope": "all-nordic", "language": "en", "start": 100, "pagination": "row-offset", "query_text": "Avanza Bank AB", "from_date": "2024-03-01", "to_date": "2024-06-15", "cache_tag": "recover-2024-q1", "rows": 100, "new_rows": 100, "total_count": null, "from_cache": false, "body_sha256": "5e70f594e1ebc482a99dd1961871ac5c55bde0aa3924335a36632ccc2ef0f92a", "recovery_target": "2024:q1" }, { "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=Cinclus+Pharma+Holding+AB&company=&market=&cnscategory=&fromDate=2024-03-01&toDate=2024-06-15&globalGroup=exchangeNotice&globalName=NordicMainMarkets&displayLanguage=sv&language=sv&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=0&dir=DESC", "status": 200, "scope": "NordicMainMarkets", "language": "sv", "start": 0, "pagination": "row-offset", "query_text": "Cinclus Pharma Holding AB", "from_date": "2024-03-01", "to_date": "2024-06-15", "cache_tag": "recover-2024-q1", "rows": 65, "new_rows": 65, "total_count": null, "from_cache": false, "body_sha256": "49ee0ea1b347cb87ffac6baaa1fcabac2067289572a75b2fe717401c10be6e67", "recovery_target": "2024:q1" }, { "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=Cinclus+Pharma+Holding+AB&company=&market=&cnscategory=&fromDate=2024-03-01&toDate=2024-06-15&globalGroup=exchangeNotice&globalName=NordicMainMarkets&displayLanguage=sv&language=sv&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=65&dir=DESC", "status": 200, "scope": "NordicMainMarkets", "language": "sv", "start": 65, "pagination": "row-offset", "query_text": "Cinclus Pharma Holding AB", "from_date": "2024-03-01", "to_date": "2024-06-15", "cache_tag": "recover-2024-q1", "rows": 0, "new_rows": 0, "total_count": null, "from_cache": false, "body_sha256": "2cb773d496282c07294c906fab8678229fe72de3a78c27092a5b06fec7a71492", "recovery_target": "2024:q1" }, { "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=Cinclus+Pharma+Holding+AB&company=&market=&cnscategory=&fromDate=2024-03-01&toDate=2024-06-15&globalGroup=exchangeNotice&globalName=NordicFirstNorth&displayLanguage=sv&language=sv&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=0&dir=DESC", "status": 200, "scope": "NordicFirstNorth", "language": "sv", "start": 0, "pagination": "row-offset", "query_text": "Cinclus Pharma Holding AB", "from_date": "2024-03-01", "to_date": "2024-06-15", "cache_tag": "recover-2024-q1", "rows": 0, "new_rows": 0, "total_count": null, "from_cache": false, "body_sha256": "f5c8bedd1257bce3d40b895a576e3ae329d320655a88f2abde9296a7a9e60889", "recovery_target": "2024:q1" }, { "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=Cinclus+Pharma+Holding+AB&company=&market=&cnscategory=&fromDate=2024-03-01&toDate=2024-06-15&globalGroup=&globalName=&displayLanguage=sv&language=sv&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=0&dir=DESC", "status": 200, "scope": "all-nordic", "language": "sv", "start": 0, "pagination": "row-offset", "query_text": "Cinclus Pharma Holding AB", "from_date": "2024-03-01", "to_date": "2024-06-15", "cache_tag": "recover-2024-q1", "rows": 65, "new_rows": 65, "total_count": null, "from_cache": false, "body_sha256": "49ee0ea1b347cb87ffac6baaa1fcabac2067289572a75b2fe717401c10be6e67", "recovery_target": "2024:q1" }, { "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=Cinclus+Pharma+Holding+AB&company=&market=&cnscategory=&fromDate=2024-03-01&toDate=2024-06-15&globalGroup=&globalName=&displayLanguage=sv&language=sv&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=65&dir=DESC", "status": 200, "scope": "all-nordic", "language": "sv", "start": 65, "pagination": "row-offset", "query_text": "Cinclus Pharma Holding AB", "from_date": "2024-03-01", "to_date": "2024-06-15", "cache_tag": "recover-2024-q1", "rows": 0, "new_rows": 0, "total_count": null, "from_cache": false, "body_sha256": "2cb773d496282c07294c906fab8678229fe72de3a78c27092a5b06fec7a71492", "recovery_target": "2024:q1" }, { "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=Cinclus+Pharma+Holding+AB&company=&market=&cnscategory=&fromDate=2024-03-01&toDate=2024-06-15&globalGroup=exchangeNotice&globalName=NordicMainMarkets&displayLanguage=en&language=en&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=0&dir=DESC", "status": 200, "scope": "NordicMainMarkets", "language": "en", "start": 0, "pagination": "row-offset", "query_text": "Cinclus Pharma Holding AB", "from_date": "2024-03-01", "to_date": "2024-06-15", "cache_tag": "recover-2024-q1", "rows": 63, "new_rows": 63, "total_count": null, "from_cache": false, "body_sha256": "3447eac8f1b5a0fe78de02788d976570261cd684d884dc8fb03f7d8716466f29", "recovery_target": "2024:q1" }, { "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=Cinclus+Pharma+Holding+AB&company=&market=&cnscategory=&fromDate=2024-03-01&toDate=2024-06-15&globalGroup=exchangeNotice&globalName=NordicMainMarkets&displayLanguage=en&language=en&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=63&dir=DESC", "status": 200, "scope": "NordicMainMarkets", "language": "en", "start": 63, "pagination": "row-offset", "query_text": "Cinclus Pharma Holding AB", "from_date": "2024-03-01", "to_date": "2024-06-15", "cache_tag": "recover-2024-q1", "rows": 0, "new_rows": 0, "total_count": null, "from_cache": false, "body_sha256": "b026fd325af1e82c24205586e820a00ac45f0e8f0d5602e4530eaa7655642655", "recovery_target": "2024:q1" }, { "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=Cinclus+Pharma+Holding+AB&company=&market=&cnscategory=&fromDate=2024-03-01&toDate=2024-06-15&globalGroup=exchangeNotice&globalName=NordicFirstNorth&displayLanguage=en&language=en&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=0&dir=DESC", "status": 200, "scope": "NordicFirstNorth", "language": "en", "start": 0, "pagination": "row-offset", "query_text": "Cinclus Pharma Holding AB", "from_date": "2024-03-01", "to_date": "2024-06-15", "cache_tag": "recover-2024-q1", "rows": 1, "new_rows": 1, "total_count": null, "from_cache": false, "body_sha256": "bffcd4cce81d536bdc531f4f5c9f3c040e9ee203d8b5a7f2de462da64d17d750", "recovery_target": "2024:q1" }, { "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=Cinclus+Pharma+Holding+AB&company=&market=&cnscategory=&fromDate=2024-03-01&toDate=2024-06-15&globalGroup=exchangeNotice&globalName=NordicFirstNorth&displayLanguage=en&language=en&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=1&dir=DESC", "status": 200, "scope": "NordicFirstNorth", "language": "en", "start": 1, "pagination": "row-offset", "query_text": "Cinclus Pharma Holding AB", "from_date": "2024-03-01", "to_date": "2024-06-15", "cache_tag": "recover-2024-q1", "rows": 0, "new_rows": 0, "total_count": null, "from_cache": false, "body_sha256": "b0baeec2e2e08d034f3e6378faf59c9d544cb3d1cd4e64d2dae5360d27808f71", "recovery_target": "2024:q1" }, { "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=Cinclus+Pharma+Holding+AB&company=&market=&cnscategory=&fromDate=2024-03-01&toDate=2024-06-15&globalGroup=&globalName=&displayLanguage=en&language=en&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=0&dir=DESC", "status": 200, "scope": "all-nordic", "language": "en", "start": 0, "pagination": "row-offset", "query_text": "Cinclus Pharma Holding AB", "from_date": "2024-03-01", "to_date": "2024-06-15", "cache_tag": "recover-2024-q1", "rows": 64, "new_rows": 64, "total_count": null, "from_cache": false, "body_sha256": "e7e9198706a9e25bd8b7d6aed54277c1b683fe4794086403560d19f6593a2da7", "recovery_target": "2024:q1" }, { "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=Cinclus+Pharma+Holding+AB&company=&market=&cnscategory=&fromDate=2024-03-01&toDate=2024-06-15&globalGroup=&globalName=&displayLanguage=en&language=en&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=64&dir=DESC", "status": 200, "scope": "all-nordic", "language": "en", "start": 64, "pagination": "row-offset", "query_text": "Cinclus Pharma Holding AB", "from_date": "2024-03-01", "to_date": "2024-06-15", "cache_tag": "recover-2024-q1", "rows": 0, "new_rows": 0, "total_count": null, "from_cache": false, "body_sha256": "e16caeed088b9ab39e67fad08643833e5ab3291342a970a0c94b14cbda4eb707", "recovery_target": "2024:q1" }, { "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=BioInvent+International+AB&company=&market=&cnscategory=&fromDate=2024-03-01&toDate=2024-06-15&globalGroup=exchangeNotice&globalName=NordicMainMarkets&displayLanguage=sv&language=sv&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=0&dir=DESC", "status": 200, "scope": "NordicMainMarkets", "language": "sv", "start": 0, "pagination": "row-offset", "query_text": "BioInvent International AB", "from_date": "2024-03-01", "to_date": "2024-06-15", "cache_tag": "recover-2024-q1", "rows": 100, "new_rows": 100, "total_count": null, "from_cache": false, "body_sha256": "71b0568f5670e1cb00591905a5b15c80bccc8fc0edd695c9ef0ed1a157d6148e", "recovery_target": "2024:q1" }, { "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=BioInvent+International+AB&company=&market=&cnscategory=&fromDate=2024-03-01&toDate=2024-06-15&globalGroup=exchangeNotice&globalName=NordicMainMarkets&displayLanguage=sv&language=sv&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=100&dir=DESC", "status": 200, "scope": "NordicMainMarkets", "language": "sv", "start": 100, "pagination": "row-offset", "query_text": "BioInvent International AB", "from_date": "2024-03-01", "to_date": "2024-06-15", "cache_tag": "recover-2024-q1", "rows": 100, "new_rows": 100, "total_count": null, "from_cache": false, "body_sha256": "d1a96dd7eba42268a49d1947b396ba43403a24a96c1aeaf127cd502a5d03f87b", "recovery_target": "2024:q1" }, { "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=BioInvent+International+AB&company=&market=&cnscategory=&fromDate=2024-03-01&toDate=2024-06-15&globalGroup=exchangeNotice&globalName=NordicFirstNorth&displayLanguage=sv&language=sv&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=0&dir=DESC", "status": 200, "scope": "NordicFirstNorth", "language": "sv", "start": 0, "pagination": "row-offset", "query_text": "BioInvent International AB", "from_date": "2024-03-01", "to_date": "2024-06-15", "cache_tag": "recover-2024-q1", "rows": 6, "new_rows": 6, "total_count": null, "from_cache": false, "body_sha256": "7d2138c2193ceaba8bd1fb8eccfaffd03ef8d103dab0ed32280ac3cf97dfe5ec", "recovery_target": "2024:q1" }, { "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=BioInvent+International+AB&company=&market=&cnscategory=&fromDate=2024-03-01&toDate=2024-06-15&globalGroup=exchangeNotice&globalName=NordicFirstNorth&displayLanguage=sv&language=sv&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=6&dir=DESC", "status": 200, "scope": "NordicFirstNorth", "language": "sv", "start": 6, "pagination": "row-offset", "query_text": "BioInvent International AB", "from_date": "2024-03-01", "to_date": "2024-06-15", "cache_tag": "recover-2024-q1", "rows": 0, "new_rows": 0, "total_count": null, "from_cache": false, "body_sha256": "bd9c05e04ff6560502e6bf3875897cb7834465fc4920a52158db62f481ce3d43", "recovery_target": "2024:q1" }, { "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=BioInvent+International+AB&company=&market=&cnscategory=&fromDate=2024-03-01&toDate=2024-06-15&globalGroup=&globalName=&displayLanguage=sv&language=sv&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=0&dir=DESC", "status": 200, "scope": "all-nordic", "language": "sv", "start": 0, "pagination": "row-offset", "query_text": "BioInvent International AB", "from_date": "2024-03-01", "to_date": "2024-06-15", "cache_tag": "recover-2024-q1", "rows": 100, "new_rows": 100, "total_count": null, "from_cache": false, "body_sha256": "87035b2197c84cce5b8187765527639eee3ca52ec5374f2c2b8dad0901da6f94", "recovery_target": "2024:q1" }, { "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=BioInvent+International+AB&company=&market=&cnscategory=&fromDate=2024-03-01&toDate=2024-06-15&globalGroup=&globalName=&displayLanguage=sv&language=sv&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=100&dir=DESC", "status": 200, "scope": "all-nordic", "language": "sv", "start": 100, "pagination": "row-offset", "query_text": "BioInvent International AB", "from_date": "2024-03-01", "to_date": "2024-06-15", "cache_tag": "recover-2024-q1", "rows": 100, "new_rows": 100, "total_count": null, "from_cache": false, "body_sha256": "ba9eb1cae253d02d3e1bba16b8c6f596b487eac0cff6df3b0d0386b6ef0f3072", "recovery_target": "2024:q1" }, { "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=BioInvent+International+AB&company=&market=&cnscategory=&fromDate=2024-03-01&toDate=2024-06-15&globalGroup=exchangeNotice&globalName=NordicMainMarkets&displayLanguage=en&language=en&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=0&dir=DESC", "status": 200, "scope": "NordicMainMarkets", "language": "en", "start": 0, "pagination": "row-offset", "query_text": "BioInvent International AB", "from_date": "2024-03-01", "to_date": "2024-06-15", "cache_tag": "recover-2024-q1", "rows": 100, "new_rows": 100, "total_count": null, "from_cache": false, "body_sha256": "62226978e75c738f0028fd73eedf8551118acd163d3f5ce8849e438cc9fc01e2", "recovery_target": "2024:q1" }, { "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=BioInvent+International+AB&company=&market=&cnscategory=&fromDate=2024-03-01&toDate=2024-06-15&globalGroup=exchangeNotice&globalName=NordicMainMarkets&displayLanguage=en&language=en&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=100&dir=DESC", "status": 200, "scope": "NordicMainMarkets", "language": "en", "start": 100, "pagination": "row-offset", "query_text": "BioInvent International AB", "from_date": "2024-03-01", "to_date": "2024-06-15", "cache_tag": "recover-2024-q1", "rows": 100, "new_rows": 100, "total_count": null, "from_cache": false, "body_sha256": "42de964744c066c7629b56ec17194fa0084efd21e506088cb5985125e2925e7c", "recovery_target": "2024:q1" }, { "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=BioInvent+International+AB&company=&market=&cnscategory=&fromDate=2024-03-01&toDate=2024-06-15&globalGroup=exchangeNotice&globalName=NordicFirstNorth&displayLanguage=en&language=en&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=0&dir=DESC", "status": 200, "scope": "NordicFirstNorth", "language": "en", "start": 0, "pagination": "row-offset", "query_text": "BioInvent International AB", "from_date": "2024-03-01", "to_date": "2024-06-15", "cache_tag": "recover-2024-q1", "rows": 5, "new_rows": 5, "total_count": null, "from_cache": false, "body_sha256": "f5b1dd2d65bd1cff4873e65438b3c185e93292b18659c34a4f310a392c2b0786", "recovery_target": "2024:q1" }, { "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=BioInvent+International+AB&company=&market=&cnscategory=&fromDate=2024-03-01&toDate=2024-06-15&globalGroup=exchangeNotice&globalName=NordicFirstNorth&displayLanguage=en&language=en&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=5&dir=DESC", "status": 200, "scope": "NordicFirstNorth", "language": "en", "start": 5, "pagination": "row-offset", "query_text": "BioInvent International AB", "from_date": "2024-03-01", "to_date": "2024-06-15", "cache_tag": "recover-2024-q1", "rows": 0, "new_rows": 0, "total_count": null, "from_cache": false, "body_sha256": "d97ee824ab5793095b25a383238d191f6e98476d65197a4c886f360e00a0680f", "recovery_target": "2024:q1" }, { "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=BioInvent+International+AB&company=&market=&cnscategory=&fromDate=2024-03-01&toDate=2024-06-15&globalGroup=&globalName=&displayLanguage=en&language=en&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=0&dir=DESC", "status": 200, "scope": "all-nordic", "language": "en", "start": 0, "pagination": "row-offset", "query_text": "BioInvent International AB", "from_date": "2024-03-01", "to_date": "2024-06-15", "cache_tag": "recover-2024-q1", "rows": 100, "new_rows": 100, "total_count": null, "from_cache": false, "body_sha256": "e081eb2b8d59764154365c17e080d70ce3319eb3366c13488d667013e8b374fe", "recovery_target": "2024:q1" }, { "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=BioInvent+International+AB&company=&market=&cnscategory=&fromDate=2024-03-01&toDate=2024-06-15&globalGroup=&globalName=&displayLanguage=en&language=en&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=100&dir=DESC", "status": 200, "scope": "all-nordic", "language": "en", "start": 100, "pagination": "row-offset", "query_text": "BioInvent International AB", "from_date": "2024-03-01", "to_date": "2024-06-15", "cache_tag": "recover-2024-q1", "rows": 100, "new_rows": 100, "total_count": null, "from_cache": false, "body_sha256": "ab8ff453f7039810cc385e5585fa13d09fb9f29ee77fd375e6902ecd5f2e9b01", "recovery_target": "2024:q1" }, { "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=Hansa+Biopharma+AB&company=&market=&cnscategory=&fromDate=2024-03-01&toDate=2024-06-15&globalGroup=exchangeNotice&globalName=NordicMainMarkets&displayLanguage=sv&language=sv&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=0&dir=DESC", "status": 200, "scope": "NordicMainMarkets", "language": "sv", "start": 0, "pagination": "row-offset", "query_text": "Hansa Biopharma AB", "from_date": "2024-03-01", "to_date": "2024-06-15", "cache_tag": "recover-2024-q1", "rows": 100, "new_rows": 100, "total_count": null, "from_cache": false, "body_sha256": "34d7a323e7d6482d3e9732e95dc067a163b61f372af926443ae5778040a8feb5", "recovery_target": "2024:q1" }, { "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=Hansa+Biopharma+AB&company=&market=&cnscategory=&fromDate=2024-03-01&toDate=2024-06-15&globalGroup=exchangeNotice&globalName=NordicMainMarkets&displayLanguage=sv&language=sv&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=100&dir=DESC", "status": 200, "scope": "NordicMainMarkets", "language": "sv", "start": 100, "pagination": "row-offset", "query_text": "Hansa Biopharma AB", "from_date": "2024-03-01", "to_date": "2024-06-15", "cache_tag": "recover-2024-q1", "rows": 100, "new_rows": 100, "total_count": null, "from_cache": false, "body_sha256": "9ea4210b08604e9abdc119897ee2d8f84e7ac4a37e115bfa89c6dab024eab648", "recovery_target": "2024:q1" }, { "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=Hansa+Biopharma+AB&company=&market=&cnscategory=&fromDate=2024-03-01&toDate=2024-06-15&globalGroup=exchangeNotice&globalName=NordicFirstNorth&displayLanguage=sv&language=sv&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=0&dir=DESC", "status": 200, "scope": "NordicFirstNorth", "language": "sv", "start": 0, "pagination": "row-offset", "query_text": "Hansa Biopharma AB", "from_date": "2024-03-01", "to_date": "2024-06-15", "cache_tag": "recover-2024-q1", "rows": 4, "new_rows": 4, "total_count": null, "from_cache": false, "body_sha256": "b46f2bbbc462e54fef31e4ebd9d8cd34f3b3672fe09a16f10632f7bf57c39d7d", "recovery_target": "2024:q1" }, { "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=Hansa+Biopharma+AB&company=&market=&cnscategory=&fromDate=2024-03-01&toDate=2024-06-15&globalGroup=exchangeNotice&globalName=NordicFirstNorth&displayLanguage=sv&language=sv&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=4&dir=DESC", "status": 200, "scope": "NordicFirstNorth", "language": "sv", "start": 4, "pagination": "row-offset", "query_text": "Hansa Biopharma AB", "from_date": "2024-03-01", "to_date": "2024-06-15", "cache_tag": "recover-2024-q1", "rows": 0, "new_rows": 0, "total_count": null, "from_cache": false, "body_sha256": "e27b60cb74ad0e336cee9c3aa3436314395a27959baa132e37b1113a29192eb8", "recovery_target": "2024:q1" }, { "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=Hansa+Biopharma+AB&company=&market=&cnscategory=&fromDate=2024-03-01&toDate=2024-06-15&globalGroup=&globalName=&displayLanguage=sv&language=sv&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=0&dir=DESC", "status": 200, "scope": "all-nordic", "language": "sv", "start": 0, "pagination": "row-offset", "query_text": "Hansa Biopharma AB", "from_date": "2024-03-01", "to_date": "2024-06-15", "cache_tag": "recover-2024-q1", "rows": 100, "new_rows": 100, "total_count": null, "from_cache": false, "body_sha256": "cd4d6bded1db11511d4841e80ad4c4223481486fc18d21ea5972af9ba310ed0b", "recovery_target": "2024:q1" }, { "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=Hansa+Biopharma+AB&company=&market=&cnscategory=&fromDate=2024-03-01&toDate=2024-06-15&globalGroup=&globalName=&displayLanguage=sv&language=sv&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=100&dir=DESC", "status": 200, "scope": "all-nordic", "language": "sv", "start": 100, "pagination": "row-offset", "query_text": "Hansa Biopharma AB", "from_date": "2024-03-01", "to_date": "2024-06-15", "cache_tag": "recover-2024-q1", "rows": 100, "new_rows": 100, "total_count": null, "from_cache": false, "body_sha256": "09bc43b736a71e3c86914d0b082aff0dc29d4f525a077dfd4a57fff3984d6992", "recovery_target": "2024:q1" }, { "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=Hansa+Biopharma+AB&company=&market=&cnscategory=&fromDate=2024-03-01&toDate=2024-06-15&globalGroup=exchangeNotice&globalName=NordicMainMarkets&displayLanguage=en&language=en&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=0&dir=DESC", "status": 200, "scope": "NordicMainMarkets", "language": "en", "start": 0, "pagination": "row-offset", "query_text": "Hansa Biopharma AB", "from_date": "2024-03-01", "to_date": "2024-06-15", "cache_tag": "recover-2024-q1", "rows": 100, "new_rows": 100, "total_count": null, "from_cache": false, "body_sha256": "69ef02cadd1bbb1d08a4731c30042a85eb0f3b7bc0a6a805a3398ddf76042374", "recovery_target": "2024:q1" }, { "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=Hansa+Biopharma+AB&company=&market=&cnscategory=&fromDate=2024-03-01&toDate=2024-06-15&globalGroup=exchangeNotice&globalName=NordicMainMarkets&displayLanguage=en&language=en&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=100&dir=DESC", "status": 200, "scope": "NordicMainMarkets", "language": "en", "start": 100, "pagination": "row-offset", "query_text": "Hansa Biopharma AB", "from_date": "2024-03-01", "to_date": "2024-06-15", "cache_tag": "recover-2024-q1", "rows": 100, "new_rows": 100, "total_count": null, "from_cache": false, "body_sha256": "3c30c7c2c29da9bdcee4c827e9a4a2697096b853ec770a236c7c4ce4988f5c11", "recovery_target": "2024:q1" }, { "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=Hansa+Biopharma+AB&company=&market=&cnscategory=&fromDate=2024-03-01&toDate=2024-06-15&globalGroup=exchangeNotice&globalName=NordicFirstNorth&displayLanguage=en&language=en&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=0&dir=DESC", "status": 200, "scope": "NordicFirstNorth", "language": "en", "start": 0, "pagination": "row-offset", "query_text": "Hansa Biopharma AB", "from_date": "2024-03-01", "to_date": "2024-06-15", "cache_tag": "recover-2024-q1", "rows": 3, "new_rows": 3, "total_count": null, "from_cache": false, "body_sha256": "4c94637e201cb28f74694036c97816bc4355504cd1553f8344a5cac9d4bd8c37", "recovery_target": "2024:q1" }, { "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=Hansa+Biopharma+AB&company=&market=&cnscategory=&fromDate=2024-03-01&toDate=2024-06-15&globalGroup=exchangeNotice&globalName=NordicFirstNorth&displayLanguage=en&language=en&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=3&dir=DESC", "status": 200, "scope": "NordicFirstNorth", "language": "en", "start": 3, "pagination": "row-offset", "query_text": "Hansa Biopharma AB", "from_date": "2024-03-01", "to_date": "2024-06-15", "cache_tag": "recover-2024-q1", "rows": 0, "new_rows": 0, "total_count": null, "from_cache": false, "body_sha256": "449de37c3458e07fa7a04e480e0ef1298d825283b8c7f36964108a8672015b9a", "recovery_target": "2024:q1" }, { "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=Hansa+Biopharma+AB&company=&market=&cnscategory=&fromDate=2024-03-01&toDate=2024-06-15&globalGroup=&globalName=&displayLanguage=en&language=en&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=0&dir=DESC", "status": 200, "scope": "all-nordic", "language": "en", "start": 0, "pagination": "row-offset", "query_text": "Hansa Biopharma AB", "from_date": "2024-03-01", "to_date": "2024-06-15", "cache_tag": "recover-2024-q1", "rows": 100, "new_rows": 100, "total_count": null, "from_cache": false, "body_sha256": "70cf21ac5a1a3e79ebc68e7ef0c7c7c3b41fa98b9c65189530ec60789d5a184b", "recovery_target": "2024:q1" }, { "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=Hansa+Biopharma+AB&company=&market=&cnscategory=&fromDate=2024-03-01&toDate=2024-06-15&globalGroup=&globalName=&displayLanguage=en&language=en&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=100&dir=DESC", "status": 200, "scope": "all-nordic", "language": "en", "start": 100, "pagination": "row-offset", "query_text": "Hansa Biopharma AB", "from_date": "2024-03-01", "to_date": "2024-06-15", "cache_tag": "recover-2024-q1", "rows": 100, "new_rows": 100, "total_count": null, "from_cache": false, "body_sha256": "2219cfa0484f212b2b40d44155e25d77132bac4c9d2188192c94b8f173cf73a7", "recovery_target": "2024:q1" }, { "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=IRLAB+Therapeutics+AB&company=&market=&cnscategory=&fromDate=2024-03-01&toDate=2024-06-15&globalGroup=exchangeNotice&globalName=NordicMainMarkets&displayLanguage=sv&language=sv&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=0&dir=DESC", "status": 200, "scope": "NordicMainMarkets", "language": "sv", "start": 0, "pagination": "row-offset", "query_text": "IRLAB Therapeutics AB", "from_date": "2024-03-01", "to_date": "2024-06-15", "cache_tag": "recover-2024-q1", "rows": 100, "new_rows": 100, "total_count": null, "from_cache": false, "body_sha256": "cc0087c5ab839833badb7c9a7def4f57cadedbe2565dc3207dc301165268c021", "recovery_target": "2024:q1" }, { "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=IRLAB+Therapeutics+AB&company=&market=&cnscategory=&fromDate=2024-03-01&toDate=2024-06-15&globalGroup=exchangeNotice&globalName=NordicMainMarkets&displayLanguage=sv&language=sv&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=100&dir=DESC", "status": 200, "scope": "NordicMainMarkets", "language": "sv", "start": 100, "pagination": "row-offset", "query_text": "IRLAB Therapeutics AB", "from_date": "2024-03-01", "to_date": "2024-06-15", "cache_tag": "recover-2024-q1", "rows": 100, "new_rows": 100, "total_count": null, "from_cache": false, "body_sha256": "eaf4ecae945c2d2be77aa35928fd44e1b252085307dc28d90de0398c8a21030a", "recovery_target": "2024:q1" }, { "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=IRLAB+Therapeutics+AB&company=&market=&cnscategory=&fromDate=2024-03-01&toDate=2024-06-15&globalGroup=exchangeNotice&globalName=NordicFirstNorth&displayLanguage=sv&language=sv&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=0&dir=DESC", "status": 200, "scope": "NordicFirstNorth", "language": "sv", "start": 0, "pagination": "row-offset", "query_text": "IRLAB Therapeutics AB", "from_date": "2024-03-01", "to_date": "2024-06-15", "cache_tag": "recover-2024-q1", "rows": 2, "new_rows": 2, "total_count": null, "from_cache": false, "body_sha256": "1f36d669c431ddc7c5b9e6ed26861148120bfd74be217b79d687cd3bc1df9722", "recovery_target": "2024:q1" }, { "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=IRLAB+Therapeutics+AB&company=&market=&cnscategory=&fromDate=2024-03-01&toDate=2024-06-15&globalGroup=exchangeNotice&globalName=NordicFirstNorth&displayLanguage=sv&language=sv&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=2&dir=DESC", "status": 200, "scope": "NordicFirstNorth", "language": "sv", "start": 2, "pagination": "row-offset", "query_text": "IRLAB Therapeutics AB", "from_date": "2024-03-01", "to_date": "2024-06-15", "cache_tag": "recover-2024-q1", "rows": 0, "new_rows": 0, "total_count": null, "from_cache": false, "body_sha256": "8cf81a327a3a8b325adfd784ef5b23173c052fd172113cb13a000ad4e443c411", "recovery_target": "2024:q1" }, { "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=IRLAB+Therapeutics+AB&company=&market=&cnscategory=&fromDate=2024-03-01&toDate=2024-06-15&globalGroup=&globalName=&displayLanguage=sv&language=sv&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=0&dir=DESC", "status": 200, "scope": "all-nordic", "language": "sv", "start": 0, "pagination": "row-offset", "query_text": "IRLAB Therapeutics AB", "from_date": "2024-03-01", "to_date": "2024-06-15", "cache_tag": "recover-2024-q1", "rows": 100, "new_rows": 100, "total_count": null, "from_cache": false, "body_sha256": "7a631065344660b4bf2a1d737a9c0e70a3891823e4aa6bc44faf048fdfca9a4c", "recovery_target": "2024:q1" }, { "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=IRLAB+Therapeutics+AB&company=&market=&cnscategory=&fromDate=2024-03-01&toDate=2024-06-15&globalGroup=&globalName=&displayLanguage=sv&language=sv&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=100&dir=DESC", "status": 200, "scope": "all-nordic", "language": "sv", "start": 100, "pagination": "row-offset", "query_text": "IRLAB Therapeutics AB", "from_date": "2024-03-01", "to_date": "2024-06-15", "cache_tag": "recover-2024-q1", "rows": 100, "new_rows": 100, "total_count": null, "from_cache": false, "body_sha256": "6beb575bada94f6d3a3666aab37105f0bd0d2bcf359408cc42c15327e88bf53a", "recovery_target": "2024:q1" }, { "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=IRLAB+Therapeutics+AB&company=&market=&cnscategory=&fromDate=2024-03-01&toDate=2024-06-15&globalGroup=exchangeNotice&globalName=NordicMainMarkets&displayLanguage=en&language=en&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=0&dir=DESC", "status": 200, "scope": "NordicMainMarkets", "language": "en", "start": 0, "pagination": "row-offset", "query_text": "IRLAB Therapeutics AB", "from_date": "2024-03-01", "to_date": "2024-06-15", "cache_tag": "recover-2024-q1", "rows": 100, "new_rows": 100, "total_count": null, "from_cache": false, "body_sha256": "05f959c521780dfcab6a8f7fce5b5799f7cdaf714dd5299240dac4b7510a3af9", "recovery_target": "2024:q1" }, { "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=IRLAB+Therapeutics+AB&company=&market=&cnscategory=&fromDate=2024-03-01&toDate=2024-06-15&globalGroup=exchangeNotice&globalName=NordicMainMarkets&displayLanguage=en&language=en&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=100&dir=DESC", "status": 200, "scope": "NordicMainMarkets", "language": "en", "start": 100, "pagination": "row-offset", "query_text": "IRLAB Therapeutics AB", "from_date": "2024-03-01", "to_date": "2024-06-15", "cache_tag": "recover-2024-q1", "rows": 100, "new_rows": 100, "total_count": null, "from_cache": false, "body_sha256": "b333e8991b52a40a03e5c48311d263d0cdfd0f3ed2e3066dc0ba10ca3ec56f22", "recovery_target": "2024:q1" }, { "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=IRLAB+Therapeutics+AB&company=&market=&cnscategory=&fromDate=2024-03-01&toDate=2024-06-15&globalGroup=exchangeNotice&globalName=NordicFirstNorth&displayLanguage=en&language=en&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=0&dir=DESC", "status": 200, "scope": "NordicFirstNorth", "language": "en", "start": 0, "pagination": "row-offset", "query_text": "IRLAB Therapeutics AB", "from_date": "2024-03-01", "to_date": "2024-06-15", "cache_tag": "recover-2024-q1", "rows": 2, "new_rows": 2, "total_count": null, "from_cache": false, "body_sha256": "c32bcbc2733d636a4b273c3ef2fe7af225789b02f47c1374f463eaea192994c0", "recovery_target": "2024:q1" }, { "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=IRLAB+Therapeutics+AB&company=&market=&cnscategory=&fromDate=2024-03-01&toDate=2024-06-15&globalGroup=exchangeNotice&globalName=NordicFirstNorth&displayLanguage=en&language=en&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=2&dir=DESC", "status": 200, "scope": "NordicFirstNorth", "language": "en", "start": 2, "pagination": "row-offset", "query_text": "IRLAB Therapeutics AB", "from_date": "2024-03-01", "to_date": "2024-06-15", "cache_tag": "recover-2024-q1", "rows": 0, "new_rows": 0, "total_count": null, "from_cache": false, "body_sha256": "8cf81a327a3a8b325adfd784ef5b23173c052fd172113cb13a000ad4e443c411", "recovery_target": "2024:q1" }, { "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=IRLAB+Therapeutics+AB&company=&market=&cnscategory=&fromDate=2024-03-01&toDate=2024-06-15&globalGroup=&globalName=&displayLanguage=en&language=en&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=0&dir=DESC", "status": 200, "scope": "all-nordic", "language": "en", "start": 0, "pagination": "row-offset", "query_text": "IRLAB Therapeutics AB", "from_date": "2024-03-01", "to_date": "2024-06-15", "cache_tag": "recover-2024-q1", "rows": 100, "new_rows": 100, "total_count": null, "from_cache": false, "body_sha256": "6a18bf7aaf8ce2a986158b53505917dc1c3e401bde1ba775226e920a345c542f", "recovery_target": "2024:q1" }, { "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=IRLAB+Therapeutics+AB&company=&market=&cnscategory=&fromDate=2024-03-01&toDate=2024-06-15&globalGroup=&globalName=&displayLanguage=en&language=en&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=100&dir=DESC", "status": 200, "scope": "all-nordic", "language": "en", "start": 100, "pagination": "row-offset", "query_text": "IRLAB Therapeutics AB", "from_date": "2024-03-01", "to_date": "2024-06-15", "cache_tag": "recover-2024-q1", "rows": 100, "new_rows": 100, "total_count": null, "from_cache": false, "body_sha256": "892509947e0e2c2973a314a94cecbed8e55572adffa233eedf4bebb79f74a918", "recovery_target": "2024:q1" }, { "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=Nanologica+AB&company=&market=&cnscategory=&fromDate=2024-03-01&toDate=2024-06-15&globalGroup=exchangeNotice&globalName=NordicMainMarkets&displayLanguage=sv&language=sv&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=0&dir=DESC", "status": 200, "scope": "NordicMainMarkets", "language": "sv", "start": 0, "pagination": "row-offset", "query_text": "Nanologica AB", "from_date": "2024-03-01", "to_date": "2024-06-15", "cache_tag": "recover-2024-q1", "rows": 100, "new_rows": 100, "total_count": null, "from_cache": false, "body_sha256": "f35469a75319861110a4132673a7105362c7aa09fa0a6631061a075595d8c41b", "recovery_target": "2024:q1" }, { "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=Nanologica+AB&company=&market=&cnscategory=&fromDate=2024-03-01&toDate=2024-06-15&globalGroup=exchangeNotice&globalName=NordicMainMarkets&displayLanguage=sv&language=sv&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=100&dir=DESC", "status": 200, "scope": "NordicMainMarkets", "language": "sv", "start": 100, "pagination": "row-offset", "query_text": "Nanologica AB", "from_date": "2024-03-01", "to_date": "2024-06-15", "cache_tag": "recover-2024-q1", "rows": 27, "new_rows": 27, "total_count": null, "from_cache": false, "body_sha256": "b79a03384bf8fafdf2cf7dcd4f8e71dec42d67cfae2ebb80c9e9e5b2de93c30a", "recovery_target": "2024:q1" }, { "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=Nanologica+AB&company=&market=&cnscategory=&fromDate=2024-03-01&toDate=2024-06-15&globalGroup=exchangeNotice&globalName=NordicFirstNorth&displayLanguage=sv&language=sv&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=0&dir=DESC", "status": 200, "scope": "NordicFirstNorth", "language": "sv", "start": 0, "pagination": "row-offset", "query_text": "Nanologica AB", "from_date": "2024-03-01", "to_date": "2024-06-15", "cache_tag": "recover-2024-q1", "rows": 8, "new_rows": 8, "total_count": null, "from_cache": false, "body_sha256": "81a1ea430e8b322cbba0b15c4766fcf38e42fd2d0bbcae7a7026ab203ae942e9", "recovery_target": "2024:q1" }, { "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=Nanologica+AB&company=&market=&cnscategory=&fromDate=2024-03-01&toDate=2024-06-15&globalGroup=exchangeNotice&globalName=NordicFirstNorth&displayLanguage=sv&language=sv&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=8&dir=DESC", "status": 200, "scope": "NordicFirstNorth", "language": "sv", "start": 8, "pagination": "row-offset", "query_text": "Nanologica AB", "from_date": "2024-03-01", "to_date": "2024-06-15", "cache_tag": "recover-2024-q1", "rows": 0, "new_rows": 0, "total_count": null, "from_cache": false, "body_sha256": "55f851bae00890b2e785c04c1fe6322bd70256e1e6d4d26272bd41a04cf045af", "recovery_target": "2024:q1" }, { "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=Nanologica+AB&company=&market=&cnscategory=&fromDate=2024-03-01&toDate=2024-06-15&globalGroup=&globalName=&displayLanguage=sv&language=sv&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=0&dir=DESC", "status": 200, "scope": "all-nordic", "language": "sv", "start": 0, "pagination": "row-offset", "query_text": "Nanologica AB", "from_date": "2024-03-01", "to_date": "2024-06-15", "cache_tag": "recover-2024-q1", "rows": 100, "new_rows": 100, "total_count": null, "from_cache": false, "body_sha256": "b753e525cb93d96bc3b9b2f9562a599f3e27fca6efbfdfe62ee055c7b4ed434f", "recovery_target": "2024:q1" }, { "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=Nanologica+AB&company=&market=&cnscategory=&fromDate=2024-03-01&toDate=2024-06-15&globalGroup=&globalName=&displayLanguage=sv&language=sv&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=100&dir=DESC", "status": 200, "scope": "all-nordic", "language": "sv", "start": 100, "pagination": "row-offset", "query_text": "Nanologica AB", "from_date": "2024-03-01", "to_date": "2024-06-15", "cache_tag": "recover-2024-q1", "rows": 35, "new_rows": 35, "total_count": null, "from_cache": false, "body_sha256": "be2c79ef470309509a78a43a66fe7e6d4d14358e8bd20fce84e24b98844b2e13", "recovery_target": "2024:q1" }, { "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=Nanologica+AB&company=&market=&cnscategory=&fromDate=2024-03-01&toDate=2024-06-15&globalGroup=exchangeNotice&globalName=NordicMainMarkets&displayLanguage=en&language=en&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=0&dir=DESC", "status": 200, "scope": "NordicMainMarkets", "language": "en", "start": 0, "pagination": "row-offset", "query_text": "Nanologica AB", "from_date": "2024-03-01", "to_date": "2024-06-15", "cache_tag": "recover-2024-q1", "rows": 100, "new_rows": 100, "total_count": null, "from_cache": false, "body_sha256": "1a38bc9218198f1c576bf7480dcbe96e77db275c40989754d7f32a8620c3318e", "recovery_target": "2024:q1" }, { "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=Nanologica+AB&company=&market=&cnscategory=&fromDate=2024-03-01&toDate=2024-06-15&globalGroup=exchangeNotice&globalName=NordicMainMarkets&displayLanguage=en&language=en&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=100&dir=DESC", "status": 200, "scope": "NordicMainMarkets", "language": "en", "start": 100, "pagination": "row-offset", "query_text": "Nanologica AB", "from_date": "2024-03-01", "to_date": "2024-06-15", "cache_tag": "recover-2024-q1", "rows": 5, "new_rows": 5, "total_count": null, "from_cache": false, "body_sha256": "511a221b04d1a302c29dfa864e6ef3976b9731c40d85fc4e815ba462dd075a99", "recovery_target": "2024:q1" }, { "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=Nanologica+AB&company=&market=&cnscategory=&fromDate=2024-03-01&toDate=2024-06-15&globalGroup=exchangeNotice&globalName=NordicFirstNorth&displayLanguage=en&language=en&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=0&dir=DESC", "status": 200, "scope": "NordicFirstNorth", "language": "en", "start": 0, "pagination": "row-offset", "query_text": "Nanologica AB", "from_date": "2024-03-01", "to_date": "2024-06-15", "cache_tag": "recover-2024-q1", "rows": 6, "new_rows": 6, "total_count": null, "from_cache": false, "body_sha256": "47fe27e22976c01f9a62bbbac69d4ab7d57b3157ee59444edc3a74242f68f7f6", "recovery_target": "2024:q1" }, { "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=Nanologica+AB&company=&market=&cnscategory=&fromDate=2024-03-01&toDate=2024-06-15&globalGroup=exchangeNotice&globalName=NordicFirstNorth&displayLanguage=en&language=en&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=6&dir=DESC", "status": 200, "scope": "NordicFirstNorth", "language": "en", "start": 6, "pagination": "row-offset", "query_text": "Nanologica AB", "from_date": "2024-03-01", "to_date": "2024-06-15", "cache_tag": "recover-2024-q1", "rows": 0, "new_rows": 0, "total_count": null, "from_cache": false, "body_sha256": "bd9c05e04ff6560502e6bf3875897cb7834465fc4920a52158db62f481ce3d43", "recovery_target": "2024:q1" }, { "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=Nanologica+AB&company=&market=&cnscategory=&fromDate=2024-03-01&toDate=2024-06-15&globalGroup=&globalName=&displayLanguage=en&language=en&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=0&dir=DESC", "status": 200, "scope": "all-nordic", "language": "en", "start": 0, "pagination": "row-offset", "query_text": "Nanologica AB", "from_date": "2024-03-01", "to_date": "2024-06-15", "cache_tag": "recover-2024-q1", "rows": 100, "new_rows": 100, "total_count": null, "from_cache": false, "body_sha256": "a01ce0f396f142084547e6cf77e061c9468fbb823c094fe9c4a9bf53c5a758f2", "recovery_target": "2024:q1" }, { "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=Nanologica+AB&company=&market=&cnscategory=&fromDate=2024-03-01&toDate=2024-06-15&globalGroup=&globalName=&displayLanguage=en&language=en&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=100&dir=DESC", "status": 200, "scope": "all-nordic", "language": "en", "start": 100, "pagination": "row-offset", "query_text": "Nanologica AB", "from_date": "2024-03-01", "to_date": "2024-06-15", "cache_tag": "recover-2024-q1", "rows": 11, "new_rows": 11, "total_count": null, "from_cache": false, "body_sha256": "efa08d840ead9542beecbe9f9019cb4d6aa77c438961e934834422b6db2be8b0", "recovery_target": "2024:q1" } ], "identity": { "slug": "azn", "instrument_id": "TX271", "resolved_url": "https://www.nasdaq.com/european-market-activity/shares/azn?id=TX271" }, "transport": "ordinary-http", "browser_used": false, "query_text": "AstraZeneca", "retrieved_at": "2026-08-03T17:15:41Z" }